rfhg_212188.1

Basic information about the TSS

---

TSS ID: rfhg_212188.1 Species: human Chr: chr19		Start: 40371737 End: 40371749 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000475983.1:-260 GeneID: 23646 HGNC/MGI_ID: HGNC:17158 UniProt_ID: Nearer transcript ids and distances:

Gene_name: phospholipase D family member 3 Gene_symbol: PLD3 Gene_synonyms: HU-K4 Gene_source: HGNC:17158

TATA-Box annotation

---

Distance to TSS:	1897
Nearest PromoterID:	NR_106854
Entrez ID:	102465477
Nearest Unigene:
Nearest Refseq:	NR_106854
Nearest Ensembl:	ENSG00000275652
Gene Name:	phospholipase D family member 3
Gene Alias:	hsa-mir-6796
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.538462
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PLD3 p2@PLD3 p3@PLD3 p4@PLD3 p5@PLD3 p6@PLD3 p7@PLD3 p8@PLD3
Sample		p1@PLD3	p2@PLD3	p3@PLD3	p4@PLD3	p5@PLD3	p6@PLD3	p7@PLD3	p8@PLD3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	7.99	21.04	0.58	0.39	0.58	0.58	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.69	21.85	1.01	0.00	0.40	1.21	0.81	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.98	20.45	0.96	0.19	0.39	0.77	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.03	20.79	0.62	0.21	0.21	0.21	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	5.62	21.37	0.90	0.67	0.45	0.67	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.14	15.70	0.39	0.19	0.58	0.19	0.39	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.24	27.89	0.65	0.44	0.00	0.87	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.30	21.80	1.45	0.73	0.97	0.24	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.98	31.84	1.28	0.64	0.64	0.64	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	5.80	27.82	4.06	1.74	1.16	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4.45	27.49	4.04	2.43	0.00	0.40	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.69	33.74	3.66	2.44	1.22	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	2.26	78.98	1.61	0.64	0.00	0.97	0.64	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	3.61	69.76	0.90	1.50	0.30	1.35	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	1.10	72.45	1.32	1.32	0.22	1.32	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	4.53	54.07	1.01	1.51	0.00	2.26	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	2.84	55.91	1.31	0.87	0.00	2.18	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	3.80	56.52	0.84	0.84	0.42	1.27	2.11	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	3.20	46.38	1.60	1.07	0.00	0.00	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	2.41	63.19	1.05	1.96	0.15	2.56	0.45	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	3.21	63.75	0.94	1.60	0.13	1.20	0.67	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	3.28	61.45	1.55	0.86	0.35	1.04	0.69	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	3.10	58.42	1.81	1.16	0.52	1.42	0.78	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	2.67	51.69	0.73	0.73	0.49	1.70	0.73	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	2.32	58.56	2.06	1.55	0.00	1.03	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	3.17	55.07	1.90	0.63	0.32	0.95	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	0.55	46.15	0.55	1.10	0.55	1.10	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	2.83	74.03	1.89	2.36	0.24	1.89	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	3.07	57.66	1.13	1.29	0.16	2.26	0.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	2.53	59.18	1.63	1.09	0.18	0.72	1.45	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	3.14	53.80	1.47	1.47	0.42	2.09	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	2.54	43.18	1.76	0.98	0.00	0.98	0.39	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	2.53	48.54	0.84	1.90	0.00	1.90	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	4.78	49.98	0.99	0.82	0.49	1.81	1.15	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1.68	61.15	1.31	0.37	0.37	2.62	1.12	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	4.02	60.74	2.49	1.15	0.19	1.72	0.57	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	3.68	67.24	1.43	1.84	0.00	2.45	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	4.23	57.22	0.40	1.41	0.60	1.21	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	2.70	53.48	0.81	1.89	0.27	2.16	1.35	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	1.68	60.02	0.48	1.44	0.48	2.16	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2.59	53.17	0.47	0.94	0.47	0.94	1.18	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	2.93	55.19	0.88	0.44	0.15	2.49	1.17	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	2.53	45.13	2.11	1.27	0.63	1.69	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3.32	55.77	1.22	1.22	0.35	1.57	1.40	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	3.21	57.42	2.01	1.61	0.40	1.20	0.20	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	2.09	59.79	1.16	2.09	0.23	2.09	1.16	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	2.16	54.94	1.44	0.48	0.24	1.20	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	2.09	49.18	1.79	0.89	0.00	1.19	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1.68	54.10	0.48	0.72	0.00	1.44	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	3.24	50.55	0.81	0.81	0.40	0.61	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	2.25	47.96	2.05	1.02	0.41	1.02	1.23	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	2.89	56.93	1.56	0.89	0.22	1.11	1.11	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	55.97	0.00	0.00	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	3.55	49.68	1.42	2.48	0.35	1.42	0.71	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	2.98	41.09	0.99	0.66	0.00	1.33	1.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	38.59	0.84	1.68	0.84	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1.84	39.04	1.84	0.46	0.00	4.59	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	1.94	41.49	0.32	1.62	0.32	3.24	0.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	2.25	40.79	1.93	0.32	0.32	1.28	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	3.46	46.21	0.94	0.31	0.00	2.51	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	1.41	43.71	2.12	2.82	0.00	1.41	0.71	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.36	39.26	0.00	1.68	0.56	2.80	1.12	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	0.80	48.56	2.39	0.00	0.80	0.80	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1.36	37.71	1.02	0.68	0.00	1.02	0.68	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	2.60	38.34	0.97	1.62	0.00	0.65	1.30	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	2.84	45.08	2.84	0.35	0.00	2.13	1.77	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	55.28	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	0.98	55.09	0.98	1.95	0.49	1.95	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.97	54.55	0.99	0.50	0.00	0.99	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	1.41	52.07	1.88	0.47	0.00	0.47	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	0.33	65.91	1.32	1.32	0.66	1.32	1.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	0.93	53.83	1.55	1.24	0.31	3.71	2.17	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	0.61	55.03	1.83	0.61	0.00	1.83	1.22	0.92
Adipocyte - breast, donor1	11376-118A8	14.10	68.74	0.16	0.32	0.48	0.79	1.74	0.48
Adipocyte - breast, donor2	11327-117E4	21.34	72.03	0.64	0.64	0.64	3.69	3.69	0.80
Adipocyte - omental, donor1	11473-119C6	18.70	81.81	0.51	0.38	0.51	0.89	0.64	0.64
Adipocyte - omental, donor2	11474-119C7	72.51	94.18	2.24	0.75	0.75	2.24	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	26.46	103.16	0.00	0.67	0.00	3.35	2.34	1.34
Adipocyte - perirenal, donor1	11476-119C9	66.99	82.94	0.00	0.64	0.00	3.19	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	41.78	0.00	0.00	1.10	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	11.74	67.29	0.45	0.00	1.35	0.00	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	12.16	123.73	0.70	0.52	0.52	1.04	1.04	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	125.75	105.41	1.37	0.39	1.17	0.59	0.39	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	251.97	70.78	1.03	0.77	0.77	1.29	1.54	2.32
Adipocyte differentiation, day04, donor3	13025-139E1	119.87	73.04	0.56	0.28	0.28	0.56	1.12	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	61.72	80.53	1.76	0.00	0.59	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	153.06	67.64	0.72	0.24	0.56	0.32	0.88	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	465.09	72.62	0.65	0.32	0.97	2.58	0.97	2.58
Adipocyte differentiation, day08, donor3	13026-139E2	130.10	57.05	0.00	0.53	1.07	1.07	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	69.00	51.75	0.56	0.00	1.11	1.11	1.11	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	105.22	55.73	0.83	0.00	0.42	0.00	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	416.68	75.10	0.75	0.50	1.26	2.51	2.01	2.76
Adipocyte differentiation, day12, donor3	13027-139E3	101.12	60.87	0.00	0.65	1.64	1.31	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	77.03	46.58	0.30	0.61	0.91	0.00	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	69.61	50.17	1.33	1.33	0.66	0.66	0.66	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	95.38	80.32	1.08	3.23	0.00	0.36	1.79	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	85.06	77.87	0.00	1.20	0.00	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	56.13	57.39	0.36	1.08	0.90	0.18	0.54	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	112.12	92.04	1.67	3.35	1.67	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	92.45	79.51	0.62	1.64	0.82	0.21	0.41	1.03
Anulus Pulposus Cell, donor1	11248-116E6	167.63	71.63	1.14	0.69	1.03	1.14	0.57	0.69
Anulus Pulposus Cell, donor2	11463-119B5	157.23	83.51	1.47	0.73	0.49	0.98	0.24	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	83.57	57.51	0.45	0.00	0.90	0.45	2.70	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	65.99	57.31	0.87	0.00	0.00	4.34	1.30	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	72.77	23.54	0.00	0.00	0.00	0.00	8.56	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	100.14	51.12	0.60	0.30	0.30	2.39	1.20	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	78.41	51.85	0.00	1.26	1.26	2.53	2.53	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	75.25	23.10	0.00	0.00	0.00	4.62	1.32	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	77.00	51.33	0.32	0.97	0.00	1.30	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	66.02	57.28	0.00	0.00	0.97	0.97	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	76.61	33.26	1.78	0.59	0.00	1.78	2.38	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	60.64	50.85	1.51	0.00	0.00	1.51	1.88	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	62.41	39.19	1.45	1.45	0.00	1.45	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	66.45	33.85	1.25	0.00	0.00	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	81.05	46.29	0.16	0.49	0.49	0.49	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	68.24	60.05	1.36	1.36	0.00	0.00	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	45.39	27.29	0.30	0.15	0.30	0.60	0.60	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	78.76	56.26	0.00	1.07	0.54	1.61	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	63.86	51.20	0.38	0.19	0.38	0.94	1.32	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	68.16	32.07	0.27	0.53	1.34	3.21	1.87	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	76.09	58.53	0.98	0.00	0.00	0.98	3.90	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	77.62	59.21	0.66	0.66	0.17	0.33	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	56.43	33.62	0.00	1.20	2.40	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	70.80	0.00	3.54	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	80.79	66.38	0.17	0.69	0.51	0.69	0.69	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	20.97	0.00	0.00	0.00	4.19	0.00	12.58
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	72.33	53.40	0.00	0.49	0.00	0.97	0.49	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	96.76	59.95	0.38	0.38	1.14	0.76	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	82.37	21.80	0.00	0.00	1.21	4.85	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	48.45	54.15	1.71	1.14	0.00	2.28	0.57	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	92.99	63.49	0.21	0.86	0.43	0.64	1.71	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	64.78	38.46	0.52	0.52	1.29	2.84	2.06	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	71.32	54.90	0.00	0.00	0.00	1.41	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	70.74	59.17	0.64	0.32	0.96	0.96	1.61	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	80.62	35.67	0.71	0.00	1.43	1.43	2.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	57.33	56.74	0.00	0.00	0.00	0.58	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	66.24	56.00	0.30	0.00	0.00	1.51	1.81	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	74.84	27.32	0.00	0.00	0.00	0.00	0.00	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	58.99	53.91	0.00	0.00	0.00	5.59	2.03	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	81.50	55.52	0.76	0.25	0.00	0.76	1.27	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	64.81	26.05	0.00	0.00	0.64	0.64	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	57.39	59.55	0.00	1.73	0.00	0.86	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	56.52	51.44	0.85	0.64	0.42	1.91	0.85	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	53.07	31.32	1.16	0.29	1.16	0.29	1.45	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	68.97	61.41	1.89	0.00	0.00	1.89	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	68.32	60.69	0.68	0.51	0.85	0.51	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	62.54	39.38	0.00	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	57.04	57.04	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	79.76	58.11	0.43	1.07	0.43	1.07	1.93	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	66.18	22.86	0.00	0.60	1.20	1.80	1.80	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	55.40	54.67	1.46	0.00	0.00	2.19	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	86.67	64.60	0.69	0.46	1.15	1.61	2.07	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	20.40	0.00	0.00	0.00	5.10	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	41.95	30.00	0.76	0.25	0.00	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	85.26	67.30	0.41	0.83	0.62	2.06	2.06	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	74.36	31.21	0.31	0.31	0.31	1.84	1.22	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	66.92	71.22	0.96	1.43	0.00	0.48	2.39	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	82.49	59.20	0.44	0.44	0.67	0.44	1.33	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	85.44	33.57	0.00	0.00	0.00	3.05	3.05	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	65.91	48.19	0.00	0.55	0.55	1.66	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	79.97	54.02	1.59	0.00	0.53	0.79	1.32	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	70.51	36.71	0.00	0.00	1.09	2.18	1.09	1.45
Astrocyte - cerebellum, donor1	11500-119F6	234.09	67.55	2.21	1.60	0.86	0.25	0.49	0.37
Astrocyte - cerebellum, donor2	11580-120F5	111.94	78.90	1.03	1.03	1.20	1.37	1.37	0.51
Astrocyte - cerebellum, donor3	11661-122F5	179.75	73.62	2.52	1.68	0.84	2.73	1.47	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	180.92	40.09	2.09	0.35	1.05	0.35	0.35	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	136.54	32.35	0.49	0.49	0.49	2.43	1.78	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	131.26	43.70	0.60	1.04	0.30	1.64	2.09	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.11	24.89	0.46	0.11	0.34	0.11	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.38	20.05	0.00	0.25	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.11	22.76	0.34	0.57	0.34	0.00	0.23	0.00
Basophils, donor1	12241-129G9	86.31	27.72	0.52	0.00	1.83	0.26	0.00	0.00
Basophils, donor2	12242-129H1	25.26	32.47	0.00	0.72	1.44	0.36	0.00	0.00
Basophils, donor3	12243-129H2	55.12	59.83	0.29	0.44	2.65	0.29	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	103.71	71.80	3.02	1.29	0.22	0.65	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	136.24	132.13	1.83	3.66	0.00	3.20	2.74	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	78.91	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.69	30.75	1.88	2.51	0.00	1.26	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	39.93	45.33	2.50	1.04	0.21	0.42	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	44.22	45.60	2.07	1.38	0.69	0.92	1.15	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	80.80	64.06	1.80	1.44	0.72	0.90	0.36	1.26
Burkitt's lymphoma cell line:DAUDI	10422-106C8	5.05	17.93	0.10	0.21	0.31	0.00	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.43	20.26	0.23	0.47	0.23	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	4.48	22.38	0.00	0.32	1.92	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	41.37	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	31.00	34.94	0.00	0.56	3.38	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	49.74	36.38	0.93	0.00	1.48	0.56	1.11	0.74
CD14+ Monocytes, donor3	11381-118B4	55.10	43.47	0.22	0.44	3.51	0.66	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1725.15	91.99	0.85	0.28	1.42	5.38	3.40	7.08
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1851.02	87.19	1.52	0.00	2.27	3.79	7.96	7.20
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1818.59	97.64	0.00	0.66	1.97	6.90	3.62	6.90
CD14+ monocytes - mock treated, donor1	11863-125A9	37.29	42.50	0.72	0.14	1.59	1.59	1.59	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	47.98	35.91	0.60	0.30	1.81	1.21	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	45.72	35.77	0.24	0.71	0.71	0.47	0.47	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.47	30.80	0.50	0.17	1.51	0.67	0.67	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	29.53	33.12	0.00	0.28	1.66	0.00	0.55	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	41.40	27.02	0.00	0.50	0.74	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	37.59	32.11	0.20	0.20	0.78	0.59	0.59	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	30.09	44.16	0.89	0.36	1.42	0.71	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	45.92	31.34	0.44	1.09	0.65	0.44	0.87	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	28.33	25.75	0.70	0.00	1.64	0.00	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	34.32	26.93	0.00	0.53	1.06	1.06	1.58	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	39.94	22.19	0.00	0.00	3.33	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	39.72	37.04	0.00	0.59	1.64	0.89	0.74	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	43.50	33.32	0.00	0.40	1.40	1.40	0.80	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	44.14	19.57	0.00	0.42	0.62	0.62	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	29.74	33.63	0.23	0.00	1.83	0.23	0.69	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	41.62	26.24	0.23	0.23	1.13	0.45	0.68	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	34.04	28.37	0.44	0.00	2.62	0.44	1.31	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	29.05	39.27	0.00	0.00	1.34	0.81	1.08	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	41.00	48.15	0.70	0.17	1.22	0.87	1.57	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	43.77	35.35	0.00	0.00	1.68	0.00	2.10	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	28.11	31.23	0.37	0.00	1.10	1.10	1.10	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	31.70	28.18	0.00	0.35	1.41	0.70	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	31.15	19.30	0.00	0.00	1.75	1.32	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	24.76	35.40	0.17	0.00	1.05	0.70	0.35	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	35.31	41.26	0.37	0.74	1.12	0.74	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	50.01	40.09	0.22	0.43	1.51	0.43	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.53	38.49	0.41	0.41	0.82	0.41	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	41.26	24.57	0.23	0.46	0.70	0.23	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	29.00	21.11	0.46	0.00	0.70	0.23	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	23.54	27.68	0.22	0.44	1.53	0.22	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	25.41	24.49	0.00	0.23	1.62	0.23	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	26.43	31.84	0.00	0.65	1.95	0.22	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	125.04	65.87	1.40	0.62	5.61	1.56	1.09	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	110.03	44.71	0.35	0.00	3.67	0.70	1.75	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	85.62	70.46	0.22	0.67	4.68	0.22	0.67	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	3.83	13.01	0.00	0.00	0.77	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	8.12	14.93	0.00	0.00	0.88	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	4.00	20.84	0.21	0.00	1.26	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	18.29	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.68	21.70	0.00	0.00	2.71	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	17.61	0.00	0.00	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	2.67	22.92	0.53	0.00	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1.61	24.12	0.54	0.54	1.61	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.70	25.97	0.00	0.00	1.40	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	22.75	2.35	0.00	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	27.68	0.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	1.64	23.84	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	1.45	24.66	0.00	0.00	2.90	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	13.13	0.00	0.00	0.00	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	48.49	11.31	0.40	0.40	0.81	0.40	1.21	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	47.94	9.59	0.40	0.00	0.80	1.20	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	13.05	0.00	1.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2.81	23.60	0.56	0.00	1.12	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	11.27	27.81	0.38	0.38	0.38	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	8.34	18.49	0.00	0.23	0.45	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	0.36	27.49	0.00	0.36	0.36	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	1.84	26.33	0.61	0.00	0.61	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	1.52	34.16	0.61	2.74	0.30	0.30	1.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	46.45	0.77	0.77	1.79	0.00	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	36.16	0.45	0.22	0.45	0.22	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	41.39	0.29	1.15	1.15	0.29	1.15	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	30.34	0.00	0.47	0.95	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	37.22	0.00	1.40	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	52.74	0.00	0.00	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.46	42.63	0.58	0.72	0.14	0.29	0.29	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1.86	35.76	0.85	1.19	0.51	1.36	0.17	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.16	33.05	0.64	0.48	0.32	0.97	0.64	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.45	26.00	0.00	0.90	1.79	0.90	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	22.71	0.35	0.00	1.40	0.70	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	31.68	0.00	0.44	0.44	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	38.79	0.00	0.84	1.69	0.00	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.21	35.53	0.42	0.21	0.42	0.00	1.04	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.34	28.40	0.33	0.67	0.00	1.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	38.61	0.54	0.54	1.63	0.82	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.54	48.24	0.00	1.61	0.54	0.00	0.00	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	57.38	3.59	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1.11	48.95	0.37	1.11	0.74	0.56	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.22	36.82	0.00	0.22	0.43	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.21	43.71	0.42	0.63	0.63	0.21	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	27.81	1.01	0.00	0.51	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	29.03	0.00	0.00	0.43	0.00	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.44	35.30	0.00	0.00	1.31	0.00	0.00	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.00	45.53	0.00	0.00	0.99	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	28.62	0.92	0.00	0.00	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	29.31	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	9.69	57.60	0.55	0.55	2.22	0.00	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	3.93	66.50	0.00	0.98	1.72	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1.54	30.80	0.00	0.00	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	4.30	39.75	0.36	0.00	2.15	0.00	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	33.24	0.00	0.00	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	30.78	0.00	0.33	0.65	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	22.90	0.38	0.75	0.38	0.00	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	0.00	36.61	0.25	1.01	0.76	0.50	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.11	17.20	0.00	0.23	0.69	0.69	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.59	9.83	0.24	0.24	0.48	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8.75	12.59	0.00	0.00	0.00	0.00	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.01	15.31	0.00	0.30	0.00	0.00	0.90	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.68	12.00	0.24	0.00	0.00	0.72	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	9.32	13.87	0.00	0.00	0.23	0.45	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.65	15.21	0.00	0.00	0.00	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	6.32	14.21	0.00	0.00	0.53	0.26	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.32	11.73	0.00	0.47	0.00	0.70	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.98	9.66	0.00	0.30	0.00	0.60	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.94	11.62	0.00	0.00	0.00	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.66	15.19	0.00	0.00	0.00	0.53	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.88	7.44	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.64	8.20	0.46	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	6.71	9.70	0.00	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.89	12.25	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	11.80	11.51	0.00	0.00	0.00	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	10.37	13.67	0.00	0.00	0.24	0.94	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	9.51	21.23	0.63	0.32	0.00	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.30	15.07	0.31	0.62	0.00	0.62	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.58	12.82	0.00	0.00	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	12.24	13.77	0.00	0.00	0.38	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.09	9.85	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.05	7.56	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.82	8.03	1.61	0.80	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.99	7.69	0.00	0.70	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	10.02	14.02	1.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	53.00	47.52	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	89.92	45.95	0.49	0.99	0.49	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	89.66	62.82	0.95	1.16	0.84	0.42	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	95.33	45.76	0.69	0.00	0.69	1.04	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	54.37	83.87	0.36	1.42	0.36	0.00	1.78	0.00
Chondrocyte - de diff, donor3	11410-118E6	122.54	81.35	1.25	0.68	1.14	3.41	1.02	1.02
Chondrocyte - re diff, donor2	11339-117F7	137.87	119.96	2.69	0.00	0.90	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	194.92	142.35	2.02	1.62	1.62	2.43	2.02	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	348.75	50.72	0.80	1.03	0.80	2.07	1.49	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	249.25	53.44	1.28	1.07	0.64	2.57	2.57	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	262.13	50.80	2.12	0.97	0.80	2.12	2.74	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	124.16	113.98	1.47	1.83	2.11	0.92	0.64	0.92
Corneal Epithelial Cells, donor1	11526-119I5	67.41	73.78	2.42	3.29	0.88	0.44	0.66	0.44
Corneal Epithelial Cells, donor2	11606-120I4	78.49	45.50	2.28	4.55	1.14	0.00	1.14	2.28
Corneal Epithelial Cells, donor3	11687-122I4	47.55	39.37	1.79	1.28	0.00	0.51	0.77	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	343.73	17.00	0.00	0.00	0.33	0.50	0.50	1.65
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	297.43	13.56	0.00	0.00	0.00	0.95	0.63	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	210.49	10.35	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	452.69	22.25	0.00	0.11	0.43	4.00	4.10	2.27
Dendritic Cells - plasmacytoid, donor1	11228-116C4	6.49	19.13	0.00	0.00	0.34	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3.26	15.02	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.97	15.00	0.00	0.00	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	29.68	35.69	0.50	0.17	0.67	0.00	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	25.82	50.46	0.59	0.59	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	32.24	48.08	0.00	0.28	1.41	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	65.27	35.78	0.39	0.39	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	41.30	69.52	0.58	1.16	0.29	1.75	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	26.35	56.94	0.71	0.24	0.71	1.41	0.71	1.18
Endothelial Cells - Artery, donor3	11413-118E9	21.21	45.76	0.35	0.53	0.88	0.00	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	20.84	66.72	0.89	0.22	0.66	0.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	25.25	87.63	3.04	1.22	0.30	1.22	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	13.53	85.70	2.54	1.13	0.56	0.56	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	32.98	84.09	3.57	1.49	0.30	0.89	1.19	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	29.16	44.26	2.60	1.04	1.04	1.56	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	29.07	64.94	2.27	1.42	0.71	1.13	0.99	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	7.20	49.61	0.00	0.00	0.80	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	102.73	52.41	0.52	1.05	1.05	2.10	2.10	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	44.23	44.60	0.37	0.50	0.62	0.50	0.50	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	34.11	41.93	0.65	0.00	0.00	0.22	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	29.80	39.69	0.12	0.12	0.49	0.00	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	37.54	31.85	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	47.50	34.93	0.70	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	55.27	40.51	0.79	0.16	0.16	0.63	0.94	0.63
Eosinophils, donor1	12244-129H3	0.00	45.74	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	8.25	0.00	0.00	1.65	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	0.00	21.40	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	62.79	53.75	2.93	1.71	0.73	0.24	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	85.29	91.53	0.00	0.00	0.00	2.08	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	48.81	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.91	82.51	0.82	0.00	0.82	2.05	1.23	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	17.85	47.96	0.33	0.55	0.44	3.83	1.75	2.30
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.17	33.69	0.22	0.98	0.43	1.73	0.98	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	49.24	45.36	1.33	0.61	0.73	1.46	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	32.48	86.25	1.36	1.50	0.82	0.27	0.41	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	54.74	97.66	2.21	1.37	0.84	3.27	2.74	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	79.84	146.24	2.37	2.63	0.53	2.11	0.53	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	39.53	55.15	0.33	0.00	0.66	1.99	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	113.86	65.32	0.45	0.91	0.00	0.91	2.27	1.36
Fibroblast - Cardiac, donor2	11345-117G4	57.60	38.66	0.76	0.00	0.00	2.27	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	136.11	55.20	0.63	0.79	0.63	1.89	1.26	2.21
Fibroblast - Cardiac, donor4	11452-119A3	111.24	81.23	1.21	1.21	1.52	0.30	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	37.31	48.48	0.51	0.89	0.38	0.89	1.14	0.89
Fibroblast - Cardiac, donor6	11460-119B2	41.39	41.39	0.15	0.30	0.45	0.30	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	187.18	122.07	2.68	2.28	1.34	0.94	0.54	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	131.15	82.40	0.43	0.43	0.86	0.43	1.73	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	98.14	62.99	0.00	0.00	1.46	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	100.56	60.66	1.38	1.15	0.92	0.00	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	193.86	105.49	1.53	1.53	0.68	1.87	0.85	1.53
Fibroblast - Dermal, donor1	11269-116G9	22.54	64.10	0.23	0.47	1.17	0.94	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	10.38	34.90	0.94	0.47	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	15.96	66.73	0.73	0.24	0.48	1.09	1.09	0.12
Fibroblast - Dermal, donor4	11450-119A1	17.64	34.48	0.57	0.34	0.68	0.34	1.24	0.68
Fibroblast - Dermal, donor5	11454-119A5	15.70	23.90	0.00	0.00	0.00	0.17	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	16.89	27.45	0.32	0.00	0.81	0.49	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	37.06	52.47	0.62	0.00	0.83	0.83	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	34.32	53.45	1.05	0.52	0.52	1.57	0.52	0.52
Fibroblast - Gingival, donor2	11318-117D4	36.24	35.45	0.26	0.26	0.13	0.92	1.19	1.05
Fibroblast - Gingival, donor3	11394-118C8	58.11	77.64	0.87	0.48	0.29	0.68	0.97	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	57.14	88.31	0.00	0.00	1.04	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	27.31	67.66	0.70	0.35	0.53	1.94	1.06	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	33.52	25.26	0.16	0.00	0.62	0.31	0.62	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.99	20.83	0.14	0.00	0.41	0.41	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.29	39.17	0.00	0.35	0.00	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	28.66	26.91	0.58	0.15	0.44	0.58	0.44	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	17.45	25.91	0.27	0.27	0.27	0.41	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	17.22	21.17	0.11	0.22	0.55	0.22	0.00	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	78.07	100.81	0.29	0.29	0.73	1.76	1.32	0.88
Fibroblast - Lung, donor1	11270-116H1	53.01	47.58	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	61.18	41.78	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	78.29	62.04	0.21	0.42	0.63	2.53	1.69	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	84.14	106.63	1.67	0.83	2.50	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	27.97	95.11	0.00	0.00	2.80	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	94.04	80.04	0.56	0.28	0.84	0.56	1.12	1.12
Fibroblast - Mammary, donor1	11540-120B1	21.52	73.48	1.22	0.41	0.41	0.00	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	11.98	55.92	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	71.48	0.00	0.00	5.96	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	34.14	32.20	0.00	0.19	0.58	0.58	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	37.92	43.23	0.61	0.00	0.61	1.21	0.61	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	20.50	51.10	0.00	0.31	0.00	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	53.81	50.76	0.00	0.00	0.38	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	23.22	49.68	0.27	0.00	0.27	0.27	0.81	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	38.74	82.46	0.35	0.35	0.70	0.58	0.70	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	51.07	28.30	0.22	0.55	0.66	0.88	0.44	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	48.56	57.91	1.22	0.81	0.61	0.00	0.20	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	55.46	48.11	0.67	0.00	0.67	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	76.70	59.30	0.79	0.40	0.00	1.58	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	58.54	64.69	0.40	0.20	0.79	0.99	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	84.90	111.72	0.53	0.53	0.89	0.71	0.71	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	22.86	69.97	0.79	0.20	1.38	0.39	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	43.92	94.47	0.60	0.30	0.30	1.20	1.50	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	34.76	78.80	0.97	1.08	0.65	0.43	0.32	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	40.49	80.98	0.51	0.51	0.25	1.01	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	39.21	85.48	0.82	0.49	1.15	0.82	0.66	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.88	72.18	0.60	1.00	1.20	0.40	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	19.49	66.61	0.60	0.80	0.80	0.70	0.40	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	35.36	77.98	0.91	0.30	0.60	0.30	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	74.06	82.27	0.33	0.41	0.91	0.50	0.58	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	215.74	148.39	1.54	1.20	0.34	2.22	1.20	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	152.39	126.45	1.31	0.99	0.99	1.97	2.30	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	75.20	65.51	0.53	0.43	1.17	0.43	0.53	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	65.28	32.22	0.34	0.34	0.51	0.34	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.74	48.77	0.31	0.16	0.47	4.23	0.78	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	14.82	27.02	0.87	0.00	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.79	29.82	0.52	0.69	0.17	0.17	0.35	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	50.75	35.65	2.08	1.82	0.00	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.78	39.60	0.26	1.28	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	83.45	13.78	0.00	0.00	0.00	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	107.20	9.57	0.64	0.00	0.64	2.55	3.19	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	82.73	32.52	0.29	0.86	0.00	2.85	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	74.18	71.15	1.65	1.93	0.55	3.03	0.83	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	86.31	40.64	1.37	1.60	0.23	1.37	2.05	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	90.55	35.27	0.79	1.19	0.59	0.99	0.59	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	73.75	62.91	0.53	0.26	0.26	2.64	0.79	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	98.17	40.12	0.65	0.65	0.65	2.94	0.00	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	118.96	32.72	0.00	0.44	0.44	3.54	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	124.79	34.77	0.42	0.71	0.57	1.84	0.99	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	156.51	48.52	0.86	1.48	0.49	3.20	2.22	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	124.10	21.49	0.54	0.00	0.00	1.61	1.07	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	118.69	49.43	1.12	0.74	0.25	2.23	1.49	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	102.85	38.34	0.83	0.69	0.14	0.55	0.97	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	85.39	22.16	0.20	0.20	0.41	2.64	1.02	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	157.22	52.02	2.05	0.91	0.23	1.60	1.83	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	126.31	40.48	1.62	1.49	0.37	1.25	1.49	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	102.29	38.25	0.22	0.00	0.44	1.09	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	170.79	70.32	2.66	1.18	0.30	6.21	1.77	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	147.67	46.73	0.64	0.95	0.48	1.91	1.75	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	157.06	47.36	0.89	0.67	0.22	0.67	1.34	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	148.00	49.60	1.41	1.01	0.60	3.43	2.82	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	177.28	49.37	1.02	1.19	0.17	1.53	1.70	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	197.65	37.06	1.15	1.33	0.62	0.80	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	221.22	84.91	2.08	2.08	0.52	1.14	1.35	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	215.86	83.51	2.05	2.56	0.34	2.05	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	162.11	55.11	1.22	1.22	0.22	0.77	1.00	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	179.87	42.60	1.00	0.58	0.75	0.58	0.83	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	194.58	41.45	1.02	1.02	0.41	0.41	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	204.04	73.03	2.48	1.44	1.65	5.57	1.44	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	191.96	74.59	1.04	2.77	0.46	1.73	1.96	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	181.94	58.20	1.83	1.00	0.33	1.67	2.17	1.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	181.41	71.86	0.66	1.32	0.44	5.29	1.32	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	196.66	85.48	1.48	2.71	0.25	3.32	2.83	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	175.38	47.82	0.81	0.49	0.81	1.62	1.13	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	200.13	96.86	2.25	2.25	0.32	6.41	2.25	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	177.95	61.78	1.33	0.76	0.57	1.80	1.52	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	137.93	55.99	0.47	0.63	0.16	2.21	1.90	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	185.80	60.51	0.91	1.22	0.30	5.17	1.22	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	169.35	58.02	1.67	1.15	0.52	0.94	1.46	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	150.40	63.23	1.10	1.54	0.00	2.42	1.32	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	195.54	68.17	1.40	1.12	0.28	3.09	2.24	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	168.14	42.68	0.56	0.56	0.56	1.02	0.83	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	168.46	35.56	0.27	0.27	0.53	2.94	1.87	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	165.70	34.43	0.31	0.31	0.15	2.75	0.61	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	173.06	39.25	0.13	0.13	0.78	1.68	1.04	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	171.86	51.77	0.00	0.81	0.27	2.44	2.17	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	297.91	66.55	0.92	0.74	0.74	6.27	3.32	2.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	324.58	74.79	2.19	1.10	0.66	5.48	3.07	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	276.70	152.73	0.99	2.98	0.00	0.99	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	319.49	67.14	0.66	1.19	0.66	3.17	2.77	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	330.88	82.12	0.81	0.20	0.81	7.26	4.24	2.22
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	539.07	222.64	6.86	4.32	1.27	1.27	1.52	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	138.35	25.68	0.40	0.20	0.20	0.60	1.39	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	98.76	32.82	0.31	0.15	0.15	1.23	1.23	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	100.86	32.12	0.41	0.41	0.41	1.02	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	95.44	13.46	0.31	0.63	0.63	0.31	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	79.96	13.28	0.00	0.57	0.57	0.57	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	93.62	18.45	0.00	1.38	0.00	0.46	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	111.37	27.22	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	123.01	21.66	1.93	1.16	0.39	1.93	1.55	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	120.34	24.07	0.00	0.00	0.00	3.21	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	81.72	22.60	0.00	0.00	0.00	1.74	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	99.92	17.90	0.33	0.33	0.98	1.63	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	119.42	23.88	0.82	0.41	0.00	0.41	2.06	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	16.66	0.00	0.00	3.33	0.00	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	88.09	23.49	0.00	1.12	0.28	2.24	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	104.59	19.28	0.00	1.31	0.00	0.98	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	93.11	38.59	0.84	0.00	0.00	3.36	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	137.09	28.63	1.91	1.27	0.00	1.27	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	115.49	24.12	0.68	1.36	0.00	2.38	1.02	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	98.14	22.97	0.00	0.00	0.00	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	148.33	41.81	0.57	1.72	0.57	1.72	1.72	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	139.70	31.08	0.89	0.59	0.59	2.96	0.59	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	182.97	16.94	3.39	0.00	0.00	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	277.52	28.99	0.83	2.07	0.83	8.28	4.97	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	218.62	30.38	0.00	1.15	0.69	5.29	2.53	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	242.35	52.68	0.00	5.27	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	209.50	29.98	1.54	0.77	0.38	3.46	2.69	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	240.57	29.34	0.65	0.33	0.00	5.22	3.26	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	141.79	24.08	1.34	1.34	0.67	4.68	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	243.10	50.08	1.93	1.54	0.77	3.47	4.24	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	222.52	44.50	1.37	2.40	0.00	1.71	2.05	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	208.72	29.82	0.00	2.48	0.00	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	170.81	50.49	2.36	0.47	0.94	6.61	3.30	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	188.29	38.02	2.41	1.81	1.21	3.62	2.41	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	185.16	35.61	2.54	3.56	0.51	3.56	1.53	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	225.74	41.88	1.20	2.39	0.00	3.99	2.79	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	210.17	50.32	2.47	2.47	0.49	5.43	3.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	128.67	36.59	4.72	3.54	0.00	1.18	2.36	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	205.96	43.18	2.33	1.75	0.00	4.67	1.75	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	223.39	48.72	1.76	0.44	0.00	3.95	3.07	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	199.21	33.91	1.70	3.39	0.00	5.09	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	241.75	38.80	2.39	2.39	0.00	0.60	2.98	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	291.63	27.17	0.97	1.46	0.00	3.88	2.91	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	86.74	53.64	0.00	0.00	0.00	2.28	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	161.75	94.39	2.49	0.42	0.00	7.07	2.08	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	34.86	40.48	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.86	86.90	0.95	0.95	0.63	2.54	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.15	91.49	0.84	1.25	1.25	0.84	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.82	21.93	0.35	0.58	0.12	0.23	0.35	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	23.80	26.67	0.34	0.34	0.34	0.68	0.17	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	24.34	23.43	0.00	0.68	0.46	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.83	24.59	0.66	0.33	0.22	0.66	0.22	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	29.87	28.80	0.21	0.43	0.00	0.43	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	19.16	19.16	0.43	0.86	0.22	0.22	0.22	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.79	23.29	0.37	0.75	0.37	0.87	0.50	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.62	26.59	0.17	0.34	0.51	0.17	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	18.90	24.99	0.64	0.32	0.96	0.96	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	31.90	67.15	1.68	0.56	0.56	2.24	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	46.31	70.11	0.00	0.43	0.43	0.87	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	21.15	0.00	0.00	0.00	0.00	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	108.99	79.72	1.41	0.71	1.41	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	161.29	86.45	1.45	2.18	1.45	0.73	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	43.88	27.62	0.17	0.52	0.52	1.22	0.17	0.00
Hepatocyte, donor1	11523-119I2	4.84	67.79	2.42	1.21	2.42	2.42	1.21	0.00
Hepatocyte, donor2	11603-120I1	14.01	70.03	0.00	0.00	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	22.70	58.90	1.84	0.61	0.61	1.23	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	27.41	0.00	0.00	0.65	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	0.00	54.53	1.92	1.57	2.97	0.35	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	149.42	45.14	1.65	0.96	0.55	0.69	0.14	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	35.02	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	80.10	60.08	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	55.38	33.23	0.00	1.38	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	50.05	0.00	2.50	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	23.74	11.87	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	33.32	2.56	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	63.99	63.99	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	61.72	30.86	0.00	0.00	0.00	3.25	0.00	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	46.68	30.01	0.00	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	65.35	29.04	3.63	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	80.73	33.09	0.00	0.00	1.32	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	70.95	29.93	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	36.67	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	49.76	28.34	0.00	0.00	0.00	0.63	1.26	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	60.32	32.48	0.00	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	29.27	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	48.45	25.20	0.00	0.00	0.00	0.65	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	64.40	30.59	0.00	0.00	0.00	0.00	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	0.00	0.00	0.00	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	64.38	32.60	0.81	1.63	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	71.37	23.51	0.42	0.84	0.00	0.00	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	60.28	35.36	0.80	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	69.25	32.31	0.00	0.92	0.00	0.00	1.85	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	61.84	29.27	0.47	0.00	0.47	0.94	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	53.51	16.33	0.91	1.81	0.00	3.63	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	44.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	57.03	34.44	2.15	0.00	0.00	2.15	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	72.42	41.93	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	32.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	59.30	28.70	0.00	0.00	0.00	0.00	0.64	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	67.44	32.81	0.00	0.00	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	48.56	34.99	0.00	0.71	0.00	0.71	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	33.18	0.00	0.00	0.00	0.00	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	64.82	35.80	0.31	0.93	0.31	1.23	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	66.73	42.14	0.00	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	37.72	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	57.02	35.46	0.70	0.00	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	59.75	88.52	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	48.63	42.15	6.48	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	47.96	61.04	2.62	0.87	0.00	0.87	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	51.75	58.49	0.00	0.00	0.00	6.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	48.78	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	61.87	58.67	0.00	0.00	0.00	1.07	3.20	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	62.34	19.40	1.39	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	65.54	37.04	0.00	0.00	0.00	5.70	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	34.06	0.92	0.92	0.92	0.92	1.84	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	78.66	3.03	3.03	0.00	0.00	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	80.71	93.13	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	47.58	62.38	6.34	0.00	0.00	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	82.42	34.35	1.88	1.47	0.33	0.65	0.41	0.49
Keratinocyte - epidermal, donor2	11349-117G8	13.47	31.62	0.59	2.93	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	4.54	27.92	0.38	0.95	0.38	0.19	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	83.78	65.61	2.27	1.14	0.34	0.79	0.23	0.34
Keratocytes, donor1	11527-119I6	104.87	71.52	1.38	1.03	1.38	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	41.01	43.36	1.17	1.17	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	66.20	60.66	0.59	0.00	0.40	0.79	0.20	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	43.96	0.00	2.20	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	134.84	52.86	1.08	2.16	0.00	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	465.48	81.08	2.08	1.04	0.46	0.81	0.35	0.46
Lens Epithelial Cells, donor3	11690-122I7	280.33	72.25	1.61	0.91	0.61	0.40	0.50	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	30.36	57.51	1.66	0.59	0.12	0.95	0.83	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.28	38.51	0.84	0.28	0.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	23.77	44.08	1.10	0.94	0.47	0.63	0.63	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	25.27	43.02	0.54	1.08	0.00	0.54	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.21	32.78	0.63	0.63	0.32	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.47	44.31	0.97	0.86	0.97	0.75	0.65	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.70	39.81	0.82	0.41	0.00	0.41	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	30.84	41.72	1.26	0.00	0.51	0.76	0.76	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	22.52	45.46	0.99	0.84	0.00	0.28	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.15	34.02	0.00	0.40	0.40	0.00	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.47	29.08	0.19	0.58	0.39	0.00	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	29.25	49.06	1.67	0.37	0.56	0.74	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.18	43.90	1.05	0.35	0.00	0.35	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	33.87	34.59	0.72	0.48	0.24	0.95	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	26.78	45.46	0.69	1.37	0.14	1.10	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.63	36.95	0.31	0.31	1.23	1.23	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	32.11	31.49	1.25	0.31	0.94	0.31	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	32.94	56.36	1.65	0.37	0.55	1.10	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.01	48.38	0.66	0.00	0.99	0.66	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	30.75	35.14	0.59	0.59	0.59	0.88	1.17	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	32.61	46.80	1.74	0.75	1.24	1.24	1.24	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	21.34	36.37	0.97	0.48	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	28.55	29.08	0.81	0.54	0.54	0.54	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.95	40.42	0.91	0.45	0.45	1.36	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	30.07	30.59	0.52	1.04	1.04	0.52	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	32.46	29.73	1.26	0.21	0.21	0.21	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	30.07	47.07	0.60	0.45	0.30	0.60	0.60	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.01	32.33	1.38	0.69	0.00	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.30	28.22	0.19	0.75	0.19	0.75	0.19	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	31.28	49.41	0.85	0.53	0.53	0.95	0.85	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.23	36.83	0.97	0.48	0.48	0.48	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	26.79	16.87	0.66	0.66	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	30.85	50.18	0.62	0.99	0.12	0.74	0.62	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.25	51.46	1.11	1.85	0.00	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	30.14	22.98	0.00	0.25	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	29.01	45.37	0.69	0.55	0.41	1.10	0.55	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.63	46.64	0.00	0.64	0.64	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	33.78	28.30	0.30	0.91	0.00	0.00	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	27.85	39.75	0.84	0.28	0.70	1.54	1.26	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.04	40.53	1.07	0.00	0.36	0.71	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	34.42	19.39	0.00	0.00	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	28.17	48.55	0.93	0.47	0.62	0.78	0.62	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.22	41.54	0.72	0.36	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.38	23.52	0.33	0.98	0.65	0.00	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	26.60	45.67	1.41	1.41	1.18	0.47	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.06	43.44	0.74	0.50	0.87	0.37	0.12	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	36.37	25.87	0.26	0.51	0.26	0.26	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	26.85	44.75	0.90	0.30	0.00	0.30	1.49	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	20.39	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.00	55.23	0.77	2.30	0.00	1.53	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	43.05	0.74	0.00	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.42	35.12	0.42	1.27	0.85	2.12	1.69	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	61.19	1.41	0.70	0.00	1.41	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	60.71	0.93	0.00	0.93	2.80	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	31.95	0.00	1.55	0.52	2.06	2.58	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	60.66	1.19	1.19	0.00	1.19	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.23	39.36	0.45	1.13	0.90	0.00	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.58	30.83	1.16	0.87	0.00	0.87	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.00	45.92	0.45	0.00	0.90	0.00	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.00	51.08	1.08	1.22	0.54	0.00	0.68	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.00	38.00	1.03	1.03	1.03	2.05	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.00	51.16	0.35	1.06	0.35	0.35	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.00	55.97	0.67	1.33	0.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.00	30.05	0.00	0.51	1.02	3.06	1.02	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.00	58.16	0.80	0.80	1.07	1.07	1.60	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.38	43.65	0.57	0.57	0.38	0.19	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.00	30.68	0.61	0.00	2.45	1.84	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.82	57.08	0.82	0.82	1.63	3.26	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.21	44.56	0.42	0.21	0.62	1.46	1.04	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.28	30.55	1.12	0.28	0.84	1.40	1.96	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	52.55	2.06	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.29	52.25	0.58	0.29	1.16	1.45	2.03	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.30	29.59	0.30	0.60	1.49	2.09	1.49	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.00	44.26	0.00	0.55	1.66	1.66	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.71	56.56	0.71	0.71	2.12	2.12	1.41	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.00	26.92	0.37	1.11	1.11	1.48	1.11	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	47.20	0.00	0.00	0.00	1.15	2.30	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.00	47.59	0.77	0.38	0.77	0.77	0.00	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	44.16	0.57	0.00	1.13	3.96	3.40	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.82	45.95	2.46	0.82	0.00	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.45	41.12	0.45	0.90	0.45	0.90	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.00	28.01	2.15	0.00	2.15	2.15	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	61.99	0.00	0.00	0.75	0.00	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1.49	44.96	1.11	0.74	0.37	1.11	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.00	28.00	1.29	0.43	0.43	0.86	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.86	59.94	2.57	0.86	0.86	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.00	46.64	1.00	2.33	1.00	1.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.60	38.61	1.21	0.60	0.00	2.41	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.00	64.70	0.71	0.00	1.42	1.42	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.69	48.81	1.37	1.37	0.69	1.37	0.69	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	35.96	1.07	0.54	1.61	1.07	1.61	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	57.24	0.67	3.37	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	0.00	41.86	1.11	0.37	0.74	1.85	2.59	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	0.00	23.26	1.16	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	42.31	2.12	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.00	51.22	0.80	0.40	0.80	0.00	2.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.00	21.81	0.00	0.73	2.18	0.00	2.18	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.00	66.69	0.77	0.00	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.49	42.42	0.99	0.00	0.99	1.48	0.99	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	27.29	0.00	1.88	0.00	0.00	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.00	54.81	0.00	1.01	1.01	0.50	2.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.00	44.61	1.35	0.45	0.45	0.00	1.35	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	24.10	0.00	0.00	0.00	0.00	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	52.11	1.34	1.34	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.39	44.97	0.39	1.56	0.78	1.56	2.35	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.00	26.39	0.00	0.66	0.66	0.66	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.00	56.04	1.04	1.04	0.00	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	57.76	0.44	1.75	0.88	0.44	0.88	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.00	26.84	0.56	0.56	0.56	3.35	2.24	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.00	46.37	0.00	0.88	1.32	0.44	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.00	47.83	0.39	0.39	0.00	1.16	1.16	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	0.00	33.42	0.00	1.52	1.52	0.00	2.53	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.44	46.62	0.96	0.00	1.44	0.00	1.92	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.00	56.05	1.59	1.19	0.40	1.19	1.19	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.61	30.99	1.22	0.00	0.61	1.22	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.00	34.59	0.69	1.38	0.00	0.00	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.38	41.04	0.76	0.38	0.76	1.14	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.00	33.57	0.52	0.52	0.52	0.52	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	35.07	1.21	1.21	0.60	0.60	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.95	44.37	1.58	0.00	0.95	1.27	1.58	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.00	28.79	1.07	0.00	1.07	1.07	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	0.00	31.03	1.15	1.15	0.00	0.00	2.87	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	1.03	47.31	2.06	1.03	1.03	1.54	0.51	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.00	31.83	0.00	3.54	1.41	0.71	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	44.83	0.57	2.27	0.57	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	0.42	43.68	1.66	0.83	0.83	1.25	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.00	27.41	0.00	0.00	1.57	1.57	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.00	51.36	0.42	0.84	0.42	0.42	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.46	53.43	0.46	0.00	0.00	0.93	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.00	24.09	0.67	0.00	1.34	1.34	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	58.28	0.53	1.07	0.53	1.07	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.40	52.94	2.83	1.21	1.21	0.81	1.62	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	28.45	0.00	0.92	1.84	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	54.24	0.89	0.00	0.89	0.00	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.57	52.43	0.57	0.57	1.71	1.71	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	34.51	0.77	0.77	0.00	3.83	0.77	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	41.04	0.55	0.00	0.55	0.55	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.45	62.81	1.78	0.45	0.89	1.78	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.26	42.37	0.52	0.26	0.52	0.26	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	53.05	1.33	0.66	0.00	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	51.97	0.00	0.00	0.00	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	716.57	47.86	0.00	0.23	1.60	1.82	2.51	1.82
Macrophage - monocyte derived, donor2	11313-117C8	650.90	31.75	0.18	0.18	0.18	1.28	2.57	1.28
Macrophage - monocyte derived, donor3	11389-118C3	783.87	43.13	0.00	0.13	0.79	3.54	4.46	2.36
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	13.28	13.81	1.06	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	25.83	35.18	0.48	2.06	0.63	0.32	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	50.17	28.49	1.11	1.67	0.56	0.56	0.56	0.28
Mammary Epithelial Cell, donor1	11273-116H4	23.22	32.48	1.30	1.00	0.20	0.10	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	28.67	26.93	1.16	0.87	0.58	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	23.20	25.69	1.00	1.25	0.50	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	33.22	43.39	0.00	0.00	0.00	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	63.15	92.03	0.32	0.43	1.08	0.43	0.32	0.11
Mast cell, donor2	11565-120D8	13.67	76.67	0.30	0.30	1.78	0.00	0.00	0.59
Mast cell, donor3	11566-120D9	17.78	85.10	0.00	0.23	2.25	1.13	0.23	0.00
Mast cell, donor4	11567-120E1	8.51	81.73	0.18	0.71	0.35	0.35	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	85.72	51.45	0.55	0.33	1.44	0.44	0.55	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	49.03	28.60	0.00	0.00	1.75	1.17	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	100.50	52.43	0.46	0.11	1.49	0.80	0.92	0.57
Mast cell, expanded, donor8	11941-126A6	49.04	62.26	0.33	0.50	1.34	0.67	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	21.99	57.11	2.19	1.09	0.60	0.30	0.30	0.20
Melanocyte - dark, donor2	11582-120F7	98.63	47.41	0.69	0.35	0.00	1.04	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	36.37	62.44	0.65	0.36	1.81	0.29	0.07	0.14
Melanocyte - light, donor1	11274-116H5	49.13	61.35	0.71	0.47	0.71	0.24	0.47	0.00
Melanocyte - light, donor2	11351-117H1	56.64	44.36	0.68	0.00	0.68	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	32.09	39.89	0.00	0.00	0.00	1.73	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	35.92	58.31	0.21	0.21	1.15	1.35	1.04	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	79.61	40.88	0.27	0.54	0.81	0.54	0.81	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	53.57	73.12	0.27	0.54	0.54	1.61	0.80	0.80
Meningeal Cells, donor1	11493-119E8	47.89	70.09	0.87	0.50	0.25	0.12	0.12	0.12
Meningeal Cells, donor2	11573-120E7	75.27	102.99	2.20	1.32	0.88	0.00	0.88	0.44
Meningeal Cells, donor3	11654-122E7	40.83	28.04	0.08	0.65	0.41	0.82	0.24	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	53.61	38.78	0.86	0.57	0.57	0.00	0.57	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	221.49	66.12	0.40	0.40	0.60	1.11	1.51	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	119.59	346.94	5.26	1.31	2.63	1.31	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	23.55	58.87	1.31	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.74	47.36	0.72	0.72	0.72	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.81	80.05	0.00	0.42	0.64	1.06	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.57	55.79	0.00	0.50	0.50	2.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	73.84	46.15	0.44	0.00	0.66	0.88	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	51.87	34.34	0.00	0.73	0.73	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	60.15	47.47	0.41	0.20	0.41	0.82	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	229.23	116.90	1.94	1.52	0.28	1.11	0.69	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	182.89	150.18	0.37	1.12	0.74	1.86	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	119.60	78.42	0.79	0.79	1.05	0.26	0.92	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	449.56	196.15	2.08	3.26	1.48	3.56	1.78	2.08
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	336.32	123.78	2.34	9.34	0.00	2.34	7.01	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	115.27	55.07	0.64	0.64	0.00	0.64	0.00	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	5.32	43.24	0.35	0.00	0.00	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	121.96	85.37	0.63	1.25	0.00	0.94	0.94	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	62.41	49.35	0.00	0.00	1.45	1.45	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	91.22	52.77	0.27	0.80	0.53	1.06	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	51.55	64.06	2.00	0.50	0.00	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	47.33	42.56	0.94	0.58	0.43	1.52	1.08	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1457.00	91.82	0.00	0.00	2.70	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1513.60	62.06	0.49	0.25	0.74	6.90	11.08	5.42
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	995.27	53.00	0.88	0.00	0.88	2.94	4.12	2.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	885.01	24.20	0.00	0.00	0.00	3.46	3.46	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1079.85	43.70	1.24	0.31	0.31	4.03	3.72	4.34
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	822.68	40.03	0.41	0.00	0.62	3.32	2.70	1.87
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	699.45	25.48	0.00	0.00	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	1484.05	57.56	0.25	0.25	0.75	9.26	7.76	10.01
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	1007.30	44.69	0.00	0.47	1.86	1.40	0.00	4.19
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	739.71	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1315.62	59.95	0.20	0.41	1.02	10.77	6.91	3.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	872.31	46.72	0.00	0.40	0.79	3.17	1.19	3.17
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	795.29	68.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1311.48	45.13	0.00	0.00	0.88	15.93	14.16	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	946.80	42.17	0.00	0.00	0.38	4.94	4.56	4.18
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	606.63	26.32	0.00	0.00	1.32	1.32	2.63	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1343.81	51.36	1.27	0.00	0.64	14.43	9.76	8.91
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	558.94	19.34	0.00	0.00	0.92	0.00	1.84	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1150.79	42.92	0.60	0.00	0.00	8.05	6.56	3.58
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	586.84	36.89	0.00	0.00	1.68	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	950.58	135.80	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1188.03	42.40	0.00	0.00	0.50	10.04	10.29	6.77
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	730.35	43.26	0.24	0.00	0.48	3.09	1.90	2.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	593.24	29.30	0.55	0.55	1.66	0.00	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1220.99	40.29	0.23	0.00	1.38	9.67	8.98	5.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	790.45	39.54	0.21	0.84	0.42	1.26	2.10	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	771.29	50.35	0.20	0.61	0.20	4.28	4.48	2.65
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1175.67	46.98	0.43	0.21	0.43	6.22	8.37	3.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	685.32	36.01	0.44	0.44	1.11	1.11	0.89	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	526.24	30.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1077.78	28.91	0.00	0.00	0.88	3.94	3.07	3.07
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	648.90	33.46	0.51	0.00	0.51	0.51	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	647.89	28.17	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1066.51	32.07	0.00	0.00	0.00	4.35	5.44	3.53
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	672.57	26.47	0.00	0.29	0.00	1.47	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	505.91	17.45	0.00	0.00	0.00	2.18	1.09	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1110.08	34.60	0.00	0.48	0.48	9.13	10.57	4.81
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	684.79	30.42	0.00	0.40	0.40	4.00	6.40	3.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	629.39	31.54	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1167.35	32.04	0.00	0.00	0.50	7.01	11.51	6.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	404.21	26.95	0.00	0.00	0.00	0.00	0.00	80.84
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	493.32	38.73	0.00	2.04	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	877.60	25.84	0.00	0.00	0.00	4.38	5.26	4.82
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	622.46	27.59	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	629.50	22.41	0.64	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1040.27	26.03	0.25	0.00	0.50	8.68	4.71	3.97
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	591.51	28.53	0.70	0.00	0.70	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	625.39	35.36	0.00	0.00	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1217.76	31.11	0.00	0.00	1.37	10.60	6.15	4.44
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	598.66	30.63	0.00	0.00	0.88	0.44	1.31	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	627.81	26.28	0.00	0.00	0.00	0.00	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1077.04	23.01	0.00	0.28	0.56	10.66	6.73	4.49
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	661.68	31.59	0.00	0.00	0.42	0.00	0.42	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	523.31	22.14	0.00	0.00	0.00	0.58	1.17	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	886.29	23.53	0.00	0.60	0.60	6.33	4.52	2.71
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	695.37	38.82	0.42	0.42	0.00	1.67	2.92	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	591.94	28.88	0.00	0.00	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	740.69	16.62	0.00	0.00	0.00	3.69	7.39	3.69
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	733.02	27.89	0.00	0.57	0.57	1.14	2.28	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	552.59	32.47	0.28	0.00	0.97	1.66	1.11	1.38
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	897.69	25.40	0.00	0.00	0.78	9.07	8.03	3.89
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	738.70	38.61	0.86	0.00	0.00	1.29	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	504.98	27.95	0.64	0.00	0.00	0.00	1.91	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	669.89	20.55	0.27	0.00	0.00	1.07	2.67	2.94
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	967.13	44.90	0.60	0.00	0.90	3.29	2.99	2.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	523.06	31.92	0.42	0.57	0.42	0.85	0.99	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	819.54	24.21	0.00	0.00	1.27	7.64	6.69	4.78
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	804.69	35.38	0.44	0.22	0.44	1.99	0.88	3.10
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	525.57	34.89	0.76	0.00	0.38	0.38	1.14	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	742.09	23.58	0.00	0.28	0.57	3.69	5.40	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	947.08	44.98	0.00	0.25	0.74	5.16	5.41	4.42
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	629.51	32.58	0.00	0.00	0.65	1.30	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	750.65	25.87	0.29	0.00	0.29	2.06	4.12	5.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	1047.78	47.29	0.29	0.29	0.29	4.04	5.19	2.88
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	895.59	49.05	0.82	0.00	0.41	1.65	2.89	4.12
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1008.59	34.84	0.00	0.00	0.60	1.79	2.08	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	749.61	30.14	0.00	0.00	0.00	7.53	7.53	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	743.20	26.73	1.78	1.78	0.00	5.35	5.35	7.13
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1464.77	52.24	0.00	0.00	0.99	14.13	10.84	5.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	891.00	32.61	0.00	0.00	1.05	19.99	11.57	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	823.76	32.62	0.20	0.00	0.79	5.34	2.37	3.76
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1064.50	66.12	0.93	0.00	0.93	2.79	8.38	4.66
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1422.88	69.85	0.00	0.38	2.25	12.02	9.39	7.51
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	878.13	43.15	0.53	0.00	0.80	10.65	5.06	3.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	679.96	27.26	0.23	0.11	0.79	2.49	2.38	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	1100.67	61.15	0.00	0.74	0.00	16.94	7.37	7.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1193.08	43.24	0.00	0.00	1.10	9.16	9.53	5.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	819.80	40.45	0.00	0.00	0.00	10.89	40.45	12.44
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	272.03	10.15	0.00	0.00	0.53	1.07	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	1004.61	54.09	0.00	0.00	0.00	15.46	11.59	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1480.57	49.49	0.00	0.00	1.01	15.15	5.05	10.10
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	394.65	11.81	0.00	0.00	0.42	4.22	4.22	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	74.91	5.45	0.00	0.00	0.00	2.72	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	76.30	1.91	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	97.99	4.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	67.97	4.53	0.00	1.51	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	28.55	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	35.89	16.31	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	565.54	14.26	0.00	9.50	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	66.79	65.49	1.08	0.43	1.08	0.22	0.86	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	85.71	78.39	0.52	1.05	1.05	2.09	4.18	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	0.00	39.38	0.00	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	0.83	45.08	0.83	0.83	0.83	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	1.71	59.51	1.14	0.19	0.38	0.76	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1.60	57.45	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.68	36.04	0.00	0.00	0.68	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	0.00	20.21	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	1.67	42.69	0.84	0.00	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	0.46	51.14	0.00	0.00	0.23	0.00	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2.16	42.97	0.54	0.00	0.54	0.27	0.00	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	0.63	62.02	1.26	1.05	0.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	111.35	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.48	42.69	0.50	0.00	0.99	1.99	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	1.35	58.74	0.00	0.81	0.27	0.81	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	1.13	50.32	0.45	0.68	0.45	0.91	0.91	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	1.63	51.44	0.65	0.00	0.82	0.65	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	0.91	80.92	0.55	1.09	0.91	0.55	0.91	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	0.53	72.67	1.06	1.59	0.53	2.12	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	40.82	1.20	0.00	0.60	1.20	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	0.66	71.21	0.98	0.33	0.33	1.31	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	0.98	62.28	0.33	0.98	0.65	0.65	0.65	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	0.18	87.31	1.41	1.23	0.88	0.35	0.35	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	0.00	59.07	0.70	1.41	1.41	1.41	1.41	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3.22	61.14	0.46	0.46	0.00	0.00	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1.29	75.84	0.64	1.29	0.96	0.00	0.96	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	1.38	91.74	1.38	0.34	0.00	2.76	1.03	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	123.89	2.53	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	0.22	80.87	1.56	0.67	0.67	0.00	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	1.27	55.04	0.00	0.00	3.39	0.42	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	3.09	63.61	0.71	0.47	0.71	0.95	0.47	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	0.43	67.82	0.86	0.86	1.29	0.86	0.43	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	63.19	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	4.00	82.97	0.67	0.67	1.33	2.00	0.67	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	1.35	67.18	0.00	0.90	0.90	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	0.79	33.33	0.00	0.00	0.40	0.79	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3.71	49.22	0.00	0.00	0.00	0.93	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	1.51	80.59	0.38	0.00	0.76	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	1.63	49.53	0.98	0.33	0.65	0.33	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.49	85.41	0.44	1.31	2.18	0.44	1.31	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	0.45	67.84	1.36	0.45	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	0.00	44.98	0.88	0.00	0.00	2.65	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	52.52	0.00	0.66	1.33	1.99	0.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.98	77.88	0.00	0.50	0.50	3.97	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.45	65.85	0.00	0.00	0.00	0.00	2.68	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	8.47	160.60	0.91	0.91	0.30	3.93	2.12	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	0.66	52.82	0.66	1.11	0.66	0.00	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	0.68	48.11	1.36	0.00	0.68	0.00	1.36	2.71
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	45.99	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	5.49	76.82	0.61	0.00	0.61	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.20	57.91	0.31	0.63	2.20	0.00	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.93	75.66	0.91	0.91	0.91	0.91	1.21	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.16	43.51	0.00	0.79	0.79	3.16	0.79	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	0.00	91.83	0.00	1.13	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	45.52	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	1.12	50.31	1.99	1.24	1.12	0.37	0.37	0.62
Myoblast, donor2	11322-117D8	3.26	60.41	2.30	0.19	1.34	0.96	0.77	1.34
Myoblast, donor3	11398-118D3	0.67	91.14	2.69	0.84	2.19	0.17	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.58	42.32	0.15	0.00	0.73	0.29	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	2.77	40.90	0.62	0.62	0.62	0.00	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	0.60	31.36	0.60	0.00	0.30	0.60	0.30	0.60
Natural Killer Cells, donor3	11387-118C1	4.97	34.42	0.37	0.55	0.92	0.37	0.00	0.18
Neural stem cells, donor1	11275-116H6	327.37	35.57	0.00	0.36	1.09	1.09	1.09	0.36
Neural stem cells, donor2	11352-117H2	285.00	46.22	3.85	5.78	3.85	0.00	1.93	0.00
Neurons, donor1	11494-119E9	125.17	56.89	2.28	2.28	3.41	1.14	0.00	0.00
Neurons, donor2	11574-120E8	155.22	49.54	2.20	1.98	2.20	1.54	0.66	0.44
Neurons, donor3	11655-122E8	74.82	37.82	2.47	0.82	0.82	1.64	1.64	0.82
Neutrophils, donor1	11233-116C9	6.50	8.35	0.00	0.00	1.86	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	17.39	0.00	0.00	2.90	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	2.44	9.77	0.00	0.00	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	263.59	129.30	2.85	1.42	1.31	0.83	0.95	1.54
Nucleus Pulposus Cell, donor2	11409-118E5	146.85	84.66	0.65	0.33	0.33	3.26	0.65	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	111.31	83.23	1.00	0.80	0.60	1.60	0.60	0.60
Olfactory epithelial cells, donor1	11933-125I7	26.98	35.24	0.00	0.00	0.55	0.96	0.96	0.83
Olfactory epithelial cells, donor2	11934-125I8	36.19	33.58	0.00	0.00	0.14	2.46	2.32	0.72
Olfactory epithelial cells, donor3	11935-125I9	27.35	43.59	0.11	0.34	0.57	0.79	0.57	0.34
Olfactory epithelial cells, donor4	11936-126A1	19.77	69.54	0.19	0.19	0.49	0.68	0.49	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	88.47	81.85	3.61	1.20	0.00	1.20	0.00	1.20
Osteoblast - differentiated, donor1	11276-116H7	198.02	110.39	0.64	0.64	1.06	1.28	0.85	0.64
Osteoblast - differentiated, donor2	11353-117H3	145.18	110.88	1.14	0.00	1.14	5.72	2.29	9.14
Osteoblast - differentiated, donor3	11425-118G3	77.59	76.35	1.24	0.62	0.62	6.21	0.62	0.62
Osteoblast, donor1	11277-116H8	145.01	39.67	0.39	1.17	0.20	0.20	0.20	0.39
Osteoblast, donor2	11354-117H4	102.54	29.50	0.70	0.00	0.00	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	109.48	57.23	0.18	1.24	1.42	0.89	1.07	0.71
Pancreatic stromal cells, donor1	11249-116E7	72.44	49.53	0.59	0.42	0.42	0.25	0.93	0.67
Pericytes, donor1	11491-119E6	216.30	230.43	6.23	3.67	1.34	2.00	1.00	1.34
Pericytes, donor2	11571-120E5	157.55	232.70	3.40	2.49	1.58	4.75	1.81	2.04
Pericytes, donor3	11652-122E5	81.58	87.69	1.63	1.22	1.63	1.42	0.81	1.63
Perineurial Cells, donor1	11499-119F5	72.56	80.13	1.70	0.90	0.57	0.34	0.34	0.11
Perineurial Cells, donor2	11579-120F4	90.91	45.36	0.74	0.46	0.46	0.64	0.28	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	33.15	48.13	1.27	0.00	3.51	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.91	35.26	0.24	0.49	1.47	0.49	1.22	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	35.85	43.35	0.26	0.26	1.94	0.13	0.78	0.13
Placental Epithelial Cells, donor1	11278-116H9	26.31	38.98	0.72	0.00	0.96	1.20	0.24	0.72
Placental Epithelial Cells, donor2	11355-117H5	99.80	104.24	1.11	5.54	0.00	3.33	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	118.97	82.06	2.36	1.18	0.79	2.55	0.98	1.57
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	20.89	83.54	0.00	0.63	1.90	6.96	2.22	2.85
Preadipocyte - breast, donor1	11467-119B9	8.82	62.47	0.75	0.56	0.75	0.94	0.56	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	21.67	84.32	0.65	0.65	1.04	0.39	0.65	0.13
Preadipocyte - breast, donor2	11328-117E5	29.04	95.91	0.45	0.68	0.90	3.60	2.48	0.90
Preadipocyte - omental, donor1	11468-119C1	18.43	88.66	0.75	0.85	1.60	0.64	0.96	0.53
Preadipocyte - omental, donor2	11329-117E6	79.00	83.37	1.31	0.44	2.18	2.18	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	27.07	103.71	1.15	0.43	2.01	1.00	0.57	0.29
Preadipocyte - perirenal, donor1	11469-119C2	73.82	114.18	0.98	1.97	0.98	1.97	2.95	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	6.45	32.86	0.92	0.92	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	11.86	37.19	0.35	0.71	0.71	1.42	0.35	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	16.01	79.01	1.02	0.68	1.02	1.53	0.68	0.17
Preadipocyte - visceral, donor1	11280-116I2	7.82	38.10	0.84	0.47	0.37	0.37	0.00	0.19
Preadipocyte - visceral, donor2	11357-117H7	23.93	44.18	0.00	0.46	0.46	1.38	1.84	1.38
Preadipocyte - visceral, donor3	11429-118G7	12.02	41.48	0.52	0.52	0.31	1.04	0.52	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	1.21	41.48	2.56	3.92	1.51	0.75	1.06	0.45
Prostate Epithelial Cells, donor2	11331-117E8	93.71	39.68	1.08	1.08	0.41	4.06	1.49	1.49
Prostate Epithelial Cells, donor3	11404-118D9	17.94	61.54	2.51	2.45	0.73	0.92	0.86	0.55
Prostate Stromal Cells, donor1	11254-116F3	114.47	38.95	0.23	0.23	0.46	0.80	0.68	0.68
Prostate Stromal Cells, donor2	11332-117E9	114.93	42.31	0.72	0.18	0.54	1.79	1.61	0.90
Prostate Stromal Cells, donor3	11405-118E1	170.39	71.22	0.94	0.42	0.52	5.21	2.40	1.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	60.22	63.14	0.36	1.46	0.73	0.73	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	44.01	42.90	0.90	0.62	0.28	0.35	0.35	0.28
Renal Epithelial Cells, donor1	11517-119H5	112.61	83.19	1.01	3.04	0.00	0.51	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	65.44	52.64	1.42	1.42	0.00	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	69.55	45.73	1.06	0.42	0.95	0.74	0.53	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	24.51	77.62	0.00	0.00	1.36	0.68	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.29	57.41	0.54	0.40	0.81	0.81	0.40	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	34.63	32.19	0.22	0.00	0.22	0.22	0.89	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	52.57	98.49	1.33	0.67	1.33	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	120.17	56.34	1.98	0.88	0.44	0.00	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	95.93	66.46	1.88	2.51	0.00	0.63	0.00	1.88
Renal Mesangial Cells, donor3	11679-122H5	138.43	70.46	1.94	1.39	0.55	0.83	0.55	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.55	42.95	0.00	0.81	0.54	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.08	37.95	0.42	0.84	0.00	0.84	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	63.06	48.79	0.19	0.39	0.39	0.19	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	116.94	38.37	0.26	0.00	0.26	0.26	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	167.42	57.99	0.85	0.57	0.85	0.28	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	139.96	33.96	0.00	0.00	0.00	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	108.14	37.89	1.51	0.00	2.01	0.50	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	86.20	75.37	0.53	0.67	1.34	0.53	0.40	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	1.79	53.60	0.89	0.00	1.79	0.89	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	0.00	34.12	0.00	0.00	1.65	2.20	1.65	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	0.58	41.76	1.16	0.58	1.16	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	0.00	41.74	0.13	0.26	0.26	0.00	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	0.00	39.82	0.50	0.10	0.10	0.40	0.30	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	0.11	41.16	0.45	0.78	0.45	0.00	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	0.12	52.35	0.62	0.50	0.50	0.12	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	0.12	43.24	0.23	0.00	0.58	0.58	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	0.00	43.45	0.69	0.92	0.23	1.39	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	0.14	55.45	0.55	0.41	0.41	0.27	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	0.30	35.25	0.00	0.30	0.45	1.36	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	0.36	33.87	0.18	0.00	0.54	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	0.00	62.69	0.57	0.43	0.14	0.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	0.21	35.74	0.32	0.00	0.11	0.54	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	0.22	41.38	1.11	0.66	0.89	0.89	0.00	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	0.00	54.87	0.19	0.19	0.19	0.19	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	0.19	39.31	0.56	0.37	0.19	0.28	0.37	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	0.19	32.51	0.56	0.00	0.38	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	0.13	52.82	0.40	0.40	0.27	0.13	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	0.10	43.22	0.19	0.49	0.49	0.68	0.10	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	0.19	39.34	0.76	0.38	0.57	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	0.11	54.36	0.21	0.11	0.32	0.32	0.32	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	0.28	30.27	0.00	0.00	1.40	0.56	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	0.34	41.87	0.00	0.00	0.51	0.17	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	0.18	39.93	0.00	0.18	0.36	0.18	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	0.00	38.51	0.37	0.86	0.98	0.49	0.25	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	0.27	46.34	0.67	0.54	0.54	0.40	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	0.00	64.63	0.71	0.00	0.24	0.71	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	0.20	36.51	0.60	0.00	0.40	0.40	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	0.00	41.62	0.47	1.17	0.00	0.70	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	0.00	60.34	0.62	0.41	0.62	0.62	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	0.44	31.19	0.22	0.22	0.44	1.33	1.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	0.00	34.47	0.63	0.00	0.21	0.21	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	0.00	57.60	1.08	0.40	0.13	0.27	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	0.17	35.93	1.02	0.34	0.17	0.17	0.34	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	0.00	45.11	0.96	0.77	0.19	0.19	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	0.00	58.46	0.00	0.34	0.34	0.17	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	0.14	36.90	0.41	0.00	0.14	0.55	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	0.00	40.55	0.49	0.00	0.66	0.33	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	0.00	60.84	0.17	0.68	0.34	0.51	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	0.15	37.58	1.04	0.00	0.15	0.00	0.44	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	0.00	46.38	0.80	0.27	0.53	0.53	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	0.14	83.37	0.28	0.41	0.41	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	0.00	47.86	0.24	0.24	0.24	0.00	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	0.40	64.49	0.20	0.60	0.20	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	0.19	74.87	0.19	0.38	0.19	1.22	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	0.00	66.73	0.70	0.70	1.05	1.40	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	0.30	72.23	0.91	0.30	0.30	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	0.37	74.41	0.73	0.61	0.49	0.86	0.73	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	0.00	80.78	0.73	1.16	0.87	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	0.61	83.35	0.61	3.04	1.83	1.22	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	0.30	75.95	0.60	0.90	0.00	0.90	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	0.45	115.13	0.90	1.13	1.36	3.62	1.81	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	0.90	114.42	1.50	1.20	0.30	2.40	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1.42	108.86	2.48	1.42	0.71	2.01	0.59	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	3.42	115.05	0.00	1.07	1.71	2.99	2.13	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	1.80	108.18	0.00	1.20	0.00	0.00	0.00	2.40
Schwann Cells, donor1	11498-119F4	69.77	81.06	0.56	0.56	0.56	1.50	0.94	0.38
Schwann Cells, donor2	11578-120F3	44.23	44.23	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	68.79	59.81	0.22	0.00	0.22	1.31	0.44	0.66
Sebocyte, donor1	11220-116B5	93.12	61.35	3.29	1.64	0.00	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	62.50	39.98	0.46	1.84	0.00	0.00	1.38	0.46
Sebocyte, donor3	11378-118B1	60.80	77.29	1.03	1.24	0.82	1.44	1.03	0.62
Sertoli Cells, donor1	11255-116F4	87.80	57.98	0.00	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	152.52	101.68	0.00	0.00	0.00	8.47	16.95	5.65
Skeletal Muscle Cells, donor1	11281-116I3	59.03	77.95	1.32	1.06	0.79	1.23	0.62	0.79
Skeletal Muscle Cells, donor2	11358-117H8	89.63	105.54	1.45	4.34	2.17	2.17	1.45	2.17
Skeletal Muscle Cells, donor3	11430-118G8	47.65	56.85	0.00	0.00	0.00	0.84	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	33.15	37.86	1.41	0.47	0.16	0.94	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	29.58	39.84	0.45	0.45	0.59	1.34	1.04	0.59
Skeletal Muscle Cells, donor6	11459-119B1	26.47	37.40	0.46	0.15	0.46	0.77	0.31	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	82.28	75.73	2.14	1.76	0.76	1.39	1.01	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	82.05	68.63	1.00	0.14	0.29	1.71	1.57	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	39.39	47.03	0.69	0.60	0.50	1.09	0.40	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	148.87	60.91	2.11	1.01	1.26	0.93	0.42	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	39.08	53.56	0.72	0.00	0.72	1.45	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	156.45	57.79	0.55	0.28	0.55	1.24	1.93	1.38
Skin - palm, donor1	10286-104F7	16.12	37.61	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	21.34	25.80	0.58	0.14	0.14	0.58	0.14	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.09	85.06	4.09	2.45	0.82	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.41	23.89	1.04	1.43	0.13	0.39	0.26	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	35.03	37.67	2.36	1.53	0.97	0.83	0.70	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	19.55	38.68	1.13	1.83	0.56	0.42	0.14	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	23.68	68.93	1.69	3.17	0.85	0.00	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	21.66	65.13	2.47	1.95	0.82	0.60	0.37	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.33	102.76	0.93	2.78	0.93	3.39	0.62	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	195.21	200.32	0.89	3.33	2.67	3.11	1.11	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.86	52.32	0.59	0.59	0.59	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	61.66	45.08	0.88	0.00	0.66	0.66	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	27.17	57.49	0.39	0.00	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	49.44	60.26	0.77	0.00	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	225.17	61.05	1.00	0.00	0.00	5.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	34.20	67.87	0.67	0.67	1.20	0.27	0.27	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	77.36	73.15	0.66	0.22	0.66	1.77	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.83	45.58	0.77	1.41	0.51	0.26	0.90	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	62.19	77.82	1.95	1.63	0.65	0.33	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	69.70	95.39	1.48	0.30	1.18	0.59	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	86.27	67.77	1.14	0.28	0.43	0.71	1.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	110.78	90.45	1.14	0.33	0.49	0.49	0.98	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	65.45	70.32	1.83	0.61	0.30	0.61	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	20.71	65.16	0.51	1.01	0.25	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	18.36	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.87	40.05	0.00	0.95	0.95	0.48	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	103.08	41.88	0.74	0.74	0.15	0.15	0.74	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	113.43	55.96	0.86	0.86	0.22	3.01	1.72	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	94.67	58.88	0.84	0.10	0.21	1.15	0.84	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	26.60	58.93	0.93	0.77	1.08	0.46	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	24.79	62.52	0.00	0.00	1.08	0.00	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.84	45.72	0.90	1.20	0.30	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	153.63	67.94	0.34	0.34	0.68	0.00	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	171.04	57.72	0.79	1.26	0.39	0.63	0.71	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	8.76	100.74	1.91	0.40	1.91	2.31	0.91	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	32.08	76.46	0.46	0.68	1.14	1.82	1.59	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	56.15	57.97	0.60	0.00	0.60	0.60	2.42	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	43.18	24.90	0.00	0.26	0.79	0.53	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	86.82	54.20	0.40	0.27	0.67	1.46	0.27	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	100.43	89.03	0.88	0.75	1.63	2.13	2.00	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	30.69	108.82	1.52	1.01	1.78	1.01	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.33	46.29	0.60	0.15	0.90	0.00	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	32.26	78.77	0.75	0.00	0.00	2.25	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	21.97	27.14	1.29	0.00	0.00	3.88	3.88	9.05
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	29.30	58.60	0.93	0.00	0.93	0.47	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	22.21	91.38	1.01	0.50	2.02	2.52	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.67	61.11	0.94	0.00	0.00	2.51	0.94	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	107.97	88.20	1.47	1.47	1.18	1.18	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.82	32.82	0.25	0.00	0.50	0.08	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	93.90	77.55	1.40	0.47	0.00	0.93	1.40	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	51.81	57.57	0.58	0.72	0.72	0.29	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	59.40	33.14	0.00	0.00	0.25	0.76	0.76	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	46.07	38.55	0.00	0.19	0.19	0.94	0.38	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	74.20	47.65	0.84	0.28	0.84	0.42	0.00	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	165.90	95.43	0.67	1.34	0.34	0.67	0.08	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	186.19	114.28	0.48	0.95	0.48	3.33	0.95	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	53.83	63.61	0.73	0.73	0.98	0.24	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	76.89	70.48	0.88	1.10	0.00	0.22	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.82	44.47	0.00	0.00	0.00	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	84.55	72.11	0.39	0.39	0.58	0.97	0.58	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	33.85	39.93	1.06	0.00	0.26	2.91	0.79	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	59.14	49.84	0.00	0.37	0.00	5.95	1.49	2.98
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	64.32	75.10	1.80	0.72	1.80	3.23	2.87	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	25.83	39.18	0.28	0.28	0.28	0.85	0.85	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.81	17.72	0.00	0.00	0.00	1.18	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	44.95	61.20	0.76	1.02	0.51	3.05	1.52	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	94.64	83.86	1.60	0.00	0.40	3.59	1.60	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	25.08	53.09	0.00	0.00	0.84	2.93	4.18	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	39.88	58.67	1.38	1.83	0.00	0.92	2.75	0.46
Synoviocyte, donor1	11291-117A4	12.12	47.47	0.67	0.34	1.01	0.50	0.34	0.34
Synoviocyte, donor2	11368-117I9	108.29	120.69	1.01	1.51	1.17	4.02	1.17	1.34
Synoviocyte, donor3	11440-118H9	67.92	103.66	1.12	0.67	0.45	3.57	1.56	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	93.98	54.67	0.71	0.36	0.71	0.71	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	110.99	59.46	0.00	1.98	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	134.76	66.45	0.46	0.69	0.69	0.69	0.69	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	27.17	34.05	1.58	1.00	0.65	0.29	0.36	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	32.47	22.81	1.16	1.55	0.39	0.39	0.39	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	34.93	30.35	1.72	2.29	0.00	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	86.49	75.04	0.98	0.86	1.48	0.49	0.25	0.49
Urethra, donor2	10319-105A4	50.36	44.96	0.00	1.80	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	59.77	69.07	1.06	1.06	0.27	0.00	0.53	1.33
Urothelial Cells, donor2	11600-120H7	57.28	48.87	0.80	1.60	0.40	1.20	0.00	0.80
Urothelial Cells, donor3	11681-122H7	75.87	68.53	2.52	1.38	0.46	0.69	0.69	0.23
Urothelial cells, donor0	11216-116B1	66.20	69.99	1.11	3.12	0.22	0.67	0.45	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	58.73	51.61	0.00	0.00	1.78	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	38.60	47.18	2.86	1.43	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.17	31.49	0.00	0.68	1.37	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.89	32.02	0.34	0.00	1.72	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	36.60	26.15	1.16	0.00	3.49	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	23.95	46.86	2.08	0.00	4.16	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	37.63	49.56	0.00	0.00	0.92	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	35.60	0.91	0.00	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	73.77	38.61	1.11	1.23	0.86	1.23	0.25	0.37
Wilms' tumor cell line:HFWT	10597-108E3	5.28	29.92	0.88	1.76	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	0.28	26.81	0.28	0.00	0.28	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	16.53	37.20	0.00	0.00	4.13	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	28.30	1.02	0.25	0.25	0.25	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.23	17.65	0.23	0.00	0.70	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.12	32.29	0.59	0.00	0.59	0.00	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.27	32.65	0.27	0.27	0.54	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	29.79	0.56	0.28	0.84	0.56	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	1.27	56.47	1.69	0.42	0.85	0.00	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	54.71	80.85	1.63	1.36	0.82	0.27	1.09	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.00	39.66	0.44	1.32	0.00	0.88	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.41	51.45	1.23	0.41	0.41	0.00	1.63	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	40.38	0.00	0.39	0.00	0.00	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	6.62	0.00	0.00	0.18	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	54.61	3.90	0.00	11.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.23	39.27	0.70	1.63	0.23	0.23	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	164.14	34.43	0.52	0.52	0.52	2.07	1.29	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	98.19	21.63	0.29	0.29	0.58	0.88	0.58	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	384.82	42.76	0.46	0.93	0.93	0.00	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.41	43.18	0.41	0.00	2.06	0.82	1.65	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	162.99	11.05	0.00	0.00	0.00	0.00	1.53	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	211.65	16.64	0.43	0.85	0.85	0.85	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	319.67	16.98	0.00	0.30	0.91	0.30	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	229.15	17.09	0.00	0.00	0.00	0.48	0.48	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	22.05	0.67	0.00	0.45	0.22	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	116.74	25.02	1.00	0.00	0.67	0.33	0.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	120.78	3.72	1.86	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.38	42.56	1.88	0.75	1.51	0.75	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	37.51	1.31	0.44	0.87	0.00	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	89.97	194.94	0.00	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.24	28.26	0.71	0.94	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	216.86	50.57	0.31	0.00	1.40	0.62	1.09	0.78
adipose, donor1	10184-103D4	86.20	51.60	0.59	0.59	0.59	5.28	0.59	1.76
adipose, donor2	10185-103D5	90.84	58.80	2.03	0.81	0.81	3.65	0.81	1.22
adipose, donor3	10186-103D6	100.20	48.74	1.91	1.09	0.27	2.45	2.45	3.00
adipose, donor4	10187-103D7	81.47	32.07	0.00	0.00	0.00	4.33	3.47	6.93
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	65.97	80.65	2.68	0.95	2.37	0.16	0.32	0.79
adrenal gland, adult, pool1	10081-102A9	65.48	50.93	0.00	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.40	35.09	0.53	0.13	0.27	0.00	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	0.00	34.30	0.36	0.36	0.36	1.07	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	17.62	106.65	0.46	0.70	1.85	0.93	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	181.22	169.05	1.69	5.41	1.69	0.34	1.01	1.35
amniotic membrane cells, donor3	12237-129G5	11.78	151.13	0.88	2.06	0.88	0.88	1.18	1.18
amygdala - adult, donor10196	10167-103B5	360.48	189.73	4.74	9.49	1.19	2.37	8.30	1.19
amygdala, adult, donor10252	10151-102I7	233.59	139.10	3.45	3.24	1.82	0.61	2.43	3.04
amygdala, newborn, donor10223	10360-105E9	182.36	53.58	2.90	2.90	1.94	1.94	0.65	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	1.02	75.76	0.89	1.27	0.76	0.25	0.38	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	16.11	27.14	0.22	0.22	0.44	0.44	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	115.24	51.44	4.01	2.00	0.00	0.33	0.33	0.67
aorta, adult, pool1	10052-101G7	33.73	93.95	0.20	0.78	1.77	0.98	0.39	1.18
appendix, adult	10189-103D9	55.89	48.51	0.00	0.39	0.78	0.00	0.78	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.69	70.16	3.78	2.06	2.06	1.72	0.34	0.69
artery, adult	10190-103E1	13.59	57.06	1.36	1.36	1.36	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	29.70	64.03	3.04	1.45	0.72	0.29	0.58	0.29
b cell line:RPMI1788	10427-106D4	4.61	18.44	0.45	0.89	0.30	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	34.96	83.79	1.66	0.28	0.28	0.83	1.11	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	0.00	24.11	0.40	0.40	0.60	0.00	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	0.00	17.91	0.17	0.00	0.50	0.00	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	164.98	24.61	0.00	0.00	0.00	0.56	0.00	2.80
bladder, adult, pool1	10011-101C2	34.87	48.24	0.33	0.11	0.98	0.76	0.33	0.22
blood, adult, pool1	10053-101G8	15.50	24.36	0.00	0.00	2.21	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	0.86	54.81	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	167.36	43.86	0.67	0.67	1.35	2.70	2.02	0.67
brain, adult, donor1	10084-102B3	206.04	152.74	4.10	10.25	1.03	4.10	1.03	0.00
brain, adult, pool1	10012-101C3	176.73	184.97	6.90	3.90	1.89	1.00	1.11	1.00
brain, fetal, pool1	10085-102B4	203.03	136.24	2.67	8.01	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	0.00	57.15	0.99	0.99	2.31	0.99	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.00	69.28	2.75	3.50	0.87	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	41.04	40.41	0.00	0.00	0.00	0.63	1.89	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.91	29.47	0.64	0.38	2.16	0.25	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	47.31	63.70	1.55	3.40	0.00	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	80.58	47.43	0.46	1.84	1.38	2.76	2.30	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	48.90	43.33	1.21	1.45	1.94	0.24	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	0.47	126.00	10.81	8.46	0.47	2.35	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	0.11	65.96	2.08	2.30	1.31	0.22	0.11	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	11.41	42.78	1.58	1.27	0.32	0.32	0.32	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.33	55.36	1.33	1.06	0.53	0.53	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	124.34	88.65	3.45	3.45	2.30	1.15	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	223.21	125.83	5.02	5.69	1.84	2.34	1.00	0.84
caudate nucleus, adult, donor10258	10379-105H1	202.50	147.48	3.06	1.53	1.53	0.76	4.58	0.76
caudate nucleus, newborn, donor10223	10354-105E3	166.64	33.69	1.83	2.20	0.73	1.46	0.00	1.46
cerebellum - adult, donor10196	10173-103C2	26.22	288.41	2.91	14.57	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	30.53	202.62	6.62	5.12	1.49	0.85	0.85	1.28
cerebellum, adult, pool1	10083-102B2	20.70	142.12	6.21	3.10	1.72	2.76	0.69	1.72
cerebellum, newborn, donor10223	10357-105E6	24.08	77.22	5.81	6.64	1.66	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	223.14	151.28	5.04	2.52	2.52	1.26	1.76	3.28
cerebrospinal fluid, donor2	10294-104G6	16.81	43.85	0.00	0.00	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	0.14	73.04	1.73	1.44	0.29	0.29	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	27.34	51.04	2.15	4.31	1.82	0.33	0.33	0.33
cervix, adult, pool1	10013-101C4	45.04	85.99	0.42	0.84	2.31	0.63	0.42	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	0.70	79.14	0.14	0.84	2.37	0.56	0.14	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	0.00	62.70	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	108.37	48.34	0.37	0.37	0.50	0.75	0.75	0.12
choriocarcinoma cell line:SCH	10785-110H2	194.18	118.90	13.18	13.55	1.85	0.49	0.86	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	1.19	66.41	2.61	1.66	0.47	0.00	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	30.20	117.96	2.28	0.57	0.57	0.28	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	56.08	111.66	0.80	1.29	1.19	1.79	0.99	1.19
chorionic membrane cells, donor3	12240-129G8	35.17	139.57	0.00	2.75	2.20	1.10	1.65	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1.01	24.24	0.00	0.00	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.56	47.83	0.00	0.58	0.58	0.38	0.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.21	48.78	0.63	0.63	0.63	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	52.39	34.92	0.51	0.00	0.51	0.00	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	63.61	37.73	0.24	0.97	0.24	0.24	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	67.19	31.15	0.41	0.61	0.20	0.61	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	100.70	26.50	0.00	0.88	0.29	0.29	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	0.26	69.59	0.52	1.04	1.30	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	0.46	36.80	0.69	0.23	0.69	0.91	0.91	0.46
clear cell carcinoma cell line:TEN	10636-108I6	52.05	35.74	0.35	0.17	0.17	0.35	0.87	0.17
colon carcinoma cell line:CACO-2	10513-107D9	0.18	25.99	1.10	2.01	0.00	0.00	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	0.00	72.60	4.94	4.18	0.38	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	21.42	55.93	0.00	1.19	0.00	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	38.66	69.68	0.71	0.00	1.29	0.12	0.12	0.12
colon, fetal, donor1	10070-101I7	43.26	50.68	0.00	0.62	0.62	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	4.58	45.84	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	14.45	10.20	0.00	0.85	0.00	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	16.15	11.62	0.15	0.15	0.15	0.15	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	20.73	16.92	0.14	0.00	0.00	0.14	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	69.54	154.46	1.66	1.11	4.64	0.88	0.11	0.11
cruciate ligament, donor2	10295-104G7	9.73	42.14	0.00	0.00	0.00	0.81	1.62	1.62
diaphragm, fetal, donor1	10069-101I6	26.48	77.05	0.00	0.00	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	168.23	111.11	2.64	2.40	3.60	1.92	1.44	2.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	14.92	0.00	0.23	0.00	0.46	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	0.00	34.62	1.80	0.77	1.28	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	0.24	81.85	2.17	1.20	1.93	0.24	0.24	0.72
ductus deferens, adult	10196-103E7	25.91	90.70	0.50	0.50	1.99	0.50	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	51.85	38.89	1.44	0.00	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	79.45	65.47	0.74	0.00	3.68	2.94	2.94	2.94
dura mater, adult, donor1	10041-101F5	222.66	102.41	0.66	1.24	1.82	0.66	0.41	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	12.21	59.29	8.88	4.89	2.00	1.33	0.67	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	17.48	38.12	0.72	1.58	0.43	0.00	0.00	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	0.00	22.20	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	0.00	25.43	0.30	0.61	0.30	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	0.31	20.38	0.62	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	0.00	18.39	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	294.30	66.03	2.01	2.01	0.67	2.35	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	70.50	70.86	1.09	0.72	1.63	0.54	0.91	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	37.47	31.04	1.29	0.48	0.80	1.45	0.48	0.96
epidermoid carcinoma cell line:A431	10426-106D3	18.34	29.12	1.67	0.67	0.33	0.22	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	17.27	40.36	0.44	0.55	0.66	0.22	0.11	0.22
epididymis, adult	10197-103E8	97.75	130.19	2.30	2.51	3.77	2.09	2.51	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	70.61	67.77	1.42	1.60	1.24	0.35	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.14	16.52	0.00	0.00	0.39	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	20.18	34.60	0.79	1.05	0.39	0.13	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	26.38	36.32	1.08	0.98	0.39	0.79	0.30	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	24.76	32.94	0.78	0.56	0.34	0.34	0.45	0.11
esophagus, adult, pool1	10015-101C6	24.42	52.13	0.85	0.85	1.17	0.21	0.21	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	112.59	148.40	4.88	5.76	4.63	0.50	0.88	0.38
eye - muscle inferior rectus, donor1	10272-104E2	9.66	55.54	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	71.54	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	90.78	2.98	4.46	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	12.61	81.40	0.00	2.29	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	23.32	0.00	0.00	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	107.54	106.02	1.27	1.27	2.29	2.03	1.02	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	0.00	26.29	0.51	0.26	0.13	0.00	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	0.00	22.55	0.00	0.00	0.95	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	367.70	231.37	7.79	5.35	3.47	1.03	0.94	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	78.67	27.62	0.60	0.60	1.20	0.60	0.60	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	0.18	139.62	3.20	1.55	3.29	0.27	0.27	0.37
gall bladder, adult	10198-103E9	48.77	67.84	0.48	0.97	0.72	1.69	1.45	0.24
gamma delta positive T cells, donor1	11937-126A2	0.54	37.58	0.00	0.00	1.61	0.54	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	1.87	41.83	0.75	0.37	0.75	0.00	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	1.06	68.43	1.69	1.90	1.27	1.48	1.69	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	6.38	85.49	1.35	2.71	1.55	0.77	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	110.01	48.86	2.46	1.31	0.33	0.16	0.33	0.82
gastric cancer cell line:GSS	10560-108A2	0.00	47.59	0.92	0.92	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.75	93.44	5.94	5.03	5.03	0.91	1.37	1.60
giant cell carcinoma cell line:LU65	10487-107B1	0.00	38.78	1.38	0.34	0.69	0.69	0.34	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	62.42	31.21	0.28	0.42	0.56	0.00	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	34.67	44.15	0.75	1.50	1.75	0.75	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	200.02	31.35	0.32	0.42	0.42	0.53	0.53	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	180.74	35.11	0.56	0.42	0.42	0.00	0.56	0.14
glioblastoma cell line:T98G	10485-107A8	0.00	43.27	0.77	1.10	0.55	0.22	0.00	0.22
glioma cell line:GI-1	10413-106B8	244.55	85.23	2.05	2.64	2.05	2.34	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	72.89	99.86	2.19	2.19	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	42.96	118.87	2.20	1.22	1.95	0.24	0.49	0.98
globus pallidus, adult, donor10258	10367-105F7	72.57	71.20	1.37	1.37	0.00	1.37	4.11	1.37
globus pallidus, newborn, donor10223	10364-105F4	82.07	35.17	2.13	1.60	0.53	0.00	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	2.45	12.24	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	43.71	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	15.68	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	8.00	55.36	1.60	0.64	0.00	0.64	0.64	0.96
hIPS +CCl2, biol_rep1	14383-156B9	112.48	26.17	0.00	0.00	0.00	0.92	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	144.49	31.09	0.46	0.00	0.46	2.29	1.37	1.83
hIPS +CCl2, biol_rep3	14385-156C2	112.07	24.48	0.00	0.00	0.00	1.29	0.00	0.64
hIPS, biol_rep1	14380-156B6	106.36	4.31	0.00	1.44	0.00	2.87	0.00	1.44
hIPS, biol_rep2	14381-156B7	101.51	15.09	0.69	0.00	0.69	0.69	2.06	1.37
hIPS, biol_rep3	14382-156B8	192.00	137.93	1.10	2.21	3.31	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	29.88	46.84	1.72	1.15	0.00	0.00	0.57	0.00
heart - mitral valve, adult	10205-103F7	38.87	91.48	0.00	0.30	0.90	0.90	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	21.44	82.63	0.52	0.26	1.57	0.78	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	10.82	24.15	0.00	0.00	1.67	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	75.91	82.85	1.63	1.22	1.02	1.43	1.84	1.43
heart, adult, diseased, donor1	10051-101G6	20.44	101.35	0.43	0.85	1.28	1.70	1.70	1.28
heart, adult, pool1	10016-101C7	23.92	73.36	0.92	0.46	0.23	0.00	0.00	0.92
heart, fetal, pool1	10046-101G1	62.33	83.17	1.54	0.62	2.16	0.31	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	116.93	95.95	1.23	1.23	0.93	1.23	1.54	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	15.46	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.00	34.92	1.33	1.10	0.00	0.00	0.11	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.00	37.38	0.61	1.09	0.36	0.24	0.36	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.10	44.16	0.51	1.72	0.51	0.30	0.30	0.30
hepatoma cell line:Li-7	10484-107A7	93.53	40.15	0.89	1.11	0.56	0.22	0.56	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	5.93	25.13	0.40	0.30	0.30	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	274.43	131.54	1.89	2.84	0.95	3.79	2.84	2.84
hippocampus, adult, donor10252	10153-102I9	145.73	115.52	5.10	1.63	2.45	0.82	1.63	2.45
hippocampus, adult, donor10258	10374-105G5	215.11	163.83	5.98	4.98	0.50	1.00	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	199.85	51.46	0.70	1.06	0.35	2.11	0.00	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	95.82	24.41	0.61	0.00	0.00	3.66	1.83	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	94.64	19.64	0.39	0.20	0.20	1.57	1.57	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	97.24	18.28	0.25	0.25	0.00	2.54	1.78	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	79.50	46.80	0.56	0.00	0.00	2.82	1.69	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	85.73	48.03	0.52	1.03	0.26	9.30	4.91	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	104.77	33.79	0.38	1.52	0.76	2.66	1.90	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	110.65	37.08	0.88	0.29	0.29	5.55	2.63	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	112.45	49.98	1.51	0.86	0.65	1.72	2.59	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	114.28	25.44	1.67	0.42	0.83	2.50	2.09	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	174.99	33.86	1.18	0.95	0.47	0.71	0.71	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	153.81	37.29	0.96	0.64	0.80	4.02	2.09	2.41
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	155.53	32.32	0.00	0.00	0.67	0.00	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	142.56	20.34	0.47	0.94	0.16	2.50	2.19	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	131.67	28.00	0.49	0.49	0.00	5.40	3.44	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	109.97	13.96	0.00	0.87	0.00	5.24	2.62	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	149.86	60.90	0.19	0.76	0.57	3.25	2.67	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	150.45	67.16	0.87	0.44	0.44	3.05	2.18	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	106.95	44.48	2.00	0.50	0.00	3.50	2.50	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	121.14	58.21	2.07	1.51	0.57	4.52	2.26	2.83
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	132.78	72.75	0.91	1.82	0.00	3.64	4.09	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	115.90	49.18	1.25	0.94	0.94	4.70	2.82	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	211.48	48.17	2.12	0.82	0.82	6.04	3.92	3.59
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	214.25	51.38	1.16	0.87	0.00	8.42	3.19	3.77
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	176.96	43.64	0.30	1.79	0.90	6.28	3.29	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	122.30	19.21	0.00	0.55	0.00	2.22	1.11	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	136.08	21.11	0.00	0.29	0.00	3.99	0.57	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	140.46	15.52	0.00	1.22	1.22	4.08	0.82	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	147.17	54.22	0.35	1.41	0.70	12.32	9.15	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	140.32	50.68	1.27	0.32	0.63	5.07	2.53	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	163.42	36.92	0.91	0.00	0.00	5.14	3.63	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	161.34	61.54	3.62	1.55	0.52	4.65	3.62	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	156.08	51.80	0.66	1.33	0.66	7.97	1.33	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	148.79	39.51	0.77	0.26	1.28	5.13	2.31	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	237.50	38.86	0.77	1.53	0.77	8.69	4.35	3.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	234.74	57.55	0.76	1.51	0.00	4.54	4.54	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	160.30	29.57	1.01	0.34	0.00	4.37	1.68	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	135.48	28.26	0.97	0.48	0.00	3.14	1.21	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	108.74	17.83	0.00	1.34	0.00	3.57	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	109.27	18.05	0.00	1.46	0.00	2.93	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	138.44	53.79	1.22	0.61	0.31	3.67	2.14	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	84.58	32.53	0.00	0.00	0.00	9.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	128.41	41.04	0.99	0.99	0.33	7.28	2.65	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	176.78	66.22	2.19	1.09	0.55	4.38	6.02	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	160.31	39.81	1.81	0.72	0.72	3.26	2.53	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	123.84	34.88	0.71	0.36	1.07	4.63	1.07	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	168.27	36.99	0.00	0.00	1.19	9.55	8.35	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	215.33	45.64	1.63	0.81	0.41	4.47	1.76	1.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	122.57	26.94	0.81	1.08	0.27	2.96	1.89	1.35
immature langerhans cells, donor1	11904-125F5	5.33	13.80	0.24	0.48	0.73	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	6.34	21.39	0.79	0.00	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	518.88	262.04	10.32	7.19	3.79	0.76	1.04	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	0.00	36.42	1.30	4.88	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	28.24	65.58	1.70	0.60	1.30	0.40	0.40	0.20
kidney, fetal, pool1	10045-101F9	110.21	97.12	1.27	1.27	2.76	0.57	0.14	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	308.04	33.52	0.57	0.43	0.43	0.43	0.71	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	0.28	53.36	1.52	1.52	0.83	0.55	1.11	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	2.75	60.37	1.65	1.47	0.37	0.18	0.18	0.37
left atrium, adult, donor1	10079-102A7	58.84	43.04	1.09	0.00	0.54	1.09	1.09	0.54
left ventricle, adult, donor1	10078-102A6	24.78	45.00	0.00	0.00	0.51	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	100.41	58.55	4.38	2.74	0.27	0.82	0.55	0.82
leiomyoma cell line:10964C	10569-108B2	150.88	83.71	0.00	0.36	0.00	10.42	3.95	2.16
leiomyoma cell line:15242A	10570-108B3	115.76	55.98	0.54	0.54	0.54	3.26	2.17	2.17
leiomyoma cell line:15425	10571-108B4	162.93	65.80	0.97	0.73	1.46	6.31	4.86	3.40
leiomyosarcoma cell line:Hs 5.T	10722-110A2	146.04	44.45	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	349.21	99.33	1.05	1.05	1.05	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.12	86.54	1.18	1.65	1.53	0.35	0.47	0.24
liposarcoma cell line:KMLS-1	10782-110G8	1.09	64.36	0.47	0.47	0.78	0.62	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	10.97	65.31	0.97	1.10	0.12	0.12	0.12	0.24
liver, adult, pool1	10018-101C9	47.32	62.88	1.30	0.97	0.81	0.16	0.49	0.16
liver, fetal, pool1	10086-102B5	54.56	12.23	0.00	0.00	0.94	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	125.26	94.49	3.06	2.33	2.62	0.00	0.87	1.60
locus coeruleus, adult, donor10252	10165-103B3	124.39	116.82	2.77	3.69	2.95	0.92	1.11	1.29
locus coeruleus, adult, donor10258	10375-105G6	167.31	111.16	4.23	2.82	3.10	7.05	5.92	2.82
locus coeruleus, newborn, donor10223	10362-105F2	87.91	37.86	2.10	1.26	0.84	0.84	0.84	2.10
lung adenocarcinoma cell line:A549	10499-107C4	6.23	73.21	3.74	3.04	1.66	0.42	0.14	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	39.30	61.36	2.07	2.76	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	14.63	36.12	0.79	1.45	0.26	0.00	0.13	0.00
lung, adult, pool1	10019-101D1	197.39	66.03	1.18	1.18	1.65	1.06	0.95	0.35
lung, fetal, donor1	10068-101I5	148.13	91.90	0.86	3.14	3.71	0.57	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	198.87	82.02	0.46	3.67	0.92	5.04	3.21	0.92
lymph node, adult, donor1	10077-102A5	96.57	24.14	0.00	0.00	0.00	1.42	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	0.22	64.66	2.63	2.85	0.88	0.66	0.66	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.75	10.72	0.15	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	1.70	25.48	1.70	0.00	2.55	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	15.54	67.93	0.44	0.00	1.33	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	18.68	67.65	1.04	0.21	0.62	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	23.23	55.95	0.47	0.24	0.95	0.00	0.00	0.24
mature adipocyte, donor4	12234-129G2	6.32	53.17	0.00	0.00	2.37	0.00	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	0.00	50.99	3.57	3.10	1.91	0.00	0.48	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	212.07	182.74	2.26	6.77	3.38	0.00	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	136.46	158.16	4.60	2.21	1.29	1.29	0.74	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	154.40	140.74	2.86	2.86	3.49	1.27	0.32	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	218.79	56.72	1.28	2.13	0.43	5.12	0.85	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	257.85	157.95	4.89	4.05	2.36	4.89	5.74	8.78
medial temporal gyrus, adult, donor10252	10156-103A3	137.52	139.22	4.03	1.27	1.27	1.91	1.06	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	221.52	102.09	1.93	1.93	3.85	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	143.54	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	272.79	76.45	3.23	2.51	2.15	2.87	1.44	0.36
medulla oblongata - adult, donor10196	10174-103C3	38.29	73.98	1.30	2.60	1.95	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	59.29	110.99	2.94	1.55	2.48	0.46	1.24	0.46
medulla oblongata, adult, pool1	10038-101F2	150.11	160.48	5.06	4.08	3.92	0.33	0.65	0.41
medulla oblongata, newborn, donor10223	10361-105F1	38.19	44.09	1.39	1.04	3.12	1.04	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	26.35	86.13	6.42	3.99	0.66	0.89	1.33	0.44
medulloblastoma cell line:ONS-76	10759-110E3	49.89	37.42	0.73	0.49	0.61	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	10.35	26.16	0.29	0.14	0.43	0.14	0.00	0.14
melanoma cell line:G-361	10465-106H6	48.86	39.09	0.81	0.27	0.54	0.54	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	3.08	45.23	0.54	0.54	0.00	1.81	1.09	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	12.34	58.16	1.76	3.52	0.00	0.88	0.88	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	48.99	47.44	3.37	2.59	0.52	0.78	1.81	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	5.52	62.91	1.07	0.61	0.00	0.46	0.31	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.36	88.53	1.27	2.00	0.91	0.36	0.73	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.15	67.08	1.24	0.83	1.24	1.66	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	58.30	103.53	1.40	0.98	0.28	1.12	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	82.42	118.62	1.16	1.73	0.19	0.96	1.93	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	66.63	84.68	2.08	0.00	2.08	3.47	2.08	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.87	134.56	2.23	1.89	1.03	1.03	0.86	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.76	105.35	0.69	1.15	0.23	1.15	1.27	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.97	74.67	1.46	0.93	0.53	0.13	0.27	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4.46	62.39	0.81	1.08	0.68	0.54	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	45.24	38.98	0.28	0.28	0.28	0.57	0.43	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	77.40	70.48	0.33	0.33	1.32	1.65	1.32	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	92.02	64.34	0.69	1.66	0.14	0.42	0.00	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.62	93.21	0.35	0.70	0.70	1.05	1.05	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.68	98.00	0.20	0.61	1.02	1.22	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.85	72.25	0.36	0.72	0.00	0.72	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	60.21	103.45	0.72	1.55	0.62	0.83	0.93	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	59.73	47.19	0.91	0.00	0.91	2.05	1.14	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	26.43	46.57	0.42	0.84	1.26	0.84	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	76.21	63.81	0.30	0.30	0.45	1.34	0.45	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	64.86	57.60	0.79	0.61	0.70	0.53	0.61	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	156.10	119.65	1.47	0.00	1.10	4.05	2.21	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	76.69	70.68	0.57	0.57	0.86	3.43	1.43	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	2.11	76.62	1.26	0.42	1.26	1.68	1.68	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	26.49	87.22	0.46	1.37	0.46	1.83	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	23.79	75.97	0.26	1.02	1.02	0.51	0.77	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	23.82	68.06	0.52	1.57	1.05	0.52	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.57	81.95	0.92	1.23	1.85	0.62	1.54	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.71	80.73	2.12	1.41	0.47	0.94	1.88	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	21.32	68.03	1.35	0.68	1.02	1.35	1.35	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	23.19	53.44	1.57	0.39	0.39	0.79	2.75	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.71	50.97	0.46	0.00	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	26.82	76.72	0.58	0.58	1.15	1.44	1.73	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.09	72.73	1.34	0.45	0.89	1.56	0.00	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	27.64	69.46	0.72	0.24	0.72	0.24	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	25.67	66.00	1.47	1.47	0.73	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	26.52	62.43	0.00	2.01	0.34	2.35	1.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	23.33	59.77	2.46	0.82	0.41	0.82	0.41	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.90	64.00	0.43	0.43	0.86	1.72	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	71.09	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	41.32	5.16	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	24.03	52.94	0.32	0.65	0.65	0.97	1.30	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	50.92	0.00	1.45	1.45	2.91	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	28.25	55.44	1.07	0.00	0.53	0.53	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	25.35	61.33	0.82	0.00	4.91	2.45	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.55	51.70	1.94	2.33	0.00	1.94	1.17	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	50.37	0.00	2.10	0.00	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	25.83	57.62	0.00	0.99	0.99	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	38.14	0.00	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.79	48.03	0.59	0.59	0.59	0.59	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	26.81	45.08	0.00	1.22	0.00	0.00	3.66	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	135.26	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	67.14	1.90	0.00	0.63	3.17	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.38	59.32	1.72	0.69	0.34	2.41	1.03	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	45.13	0.00	4.30	0.00	4.30	4.30	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	51.89	0.00	0.00	3.99	0.00	3.99	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	96.43	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	37.49	103.90	0.81	1.63	0.81	2.85	0.81	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	34.16	108.84	0.79	0.00	0.00	3.18	3.18	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	33.60	99.04	1.77	0.59	0.59	0.59	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.11	102.24	1.56	1.56	0.62	2.18	1.25	1.87
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	133.67	0.00	1.34	1.34	5.35	6.68	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	29.57	100.53	0.00	1.18	1.18	1.18	4.73	4.73
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	74.47	0.00	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	42.68	103.95	0.00	0.00	1.38	1.38	2.75	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	65.31	56.41	0.99	0.49	0.00	1.48	1.98	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	58.32	50.47	0.00	0.00	0.00	4.49	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	48.34	53.43	0.00	0.64	2.54	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	68.10	46.34	0.40	0.00	0.81	1.61	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	65.42	58.88	2.18	2.18	2.18	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	76.02	59.55	0.00	0.00	1.27	2.53	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	40.05	43.09	0.00	0.61	0.61	0.00	1.21	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	45.19	0.00	4.52	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	33.77	51.89	0.82	0.00	0.82	0.00	4.12	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	44.05	52.19	0.60	0.20	0.79	0.79	0.79	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	49.65	77.23	0.00	0.00	0.65	0.97	1.95	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	47.88	63.15	0.00	0.00	1.02	2.04	3.06	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	0.00	98.26	0.00	0.77	0.77	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	9.69	40.87	0.47	0.24	1.42	0.00	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	1.62	60.93	0.70	1.62	0.00	0.70	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	34.19	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	0.41	29.90	0.10	0.82	0.62	0.62	0.00	0.41
mesothelioma cell line:Mero-25	10850-111F4	8.40	29.05	0.45	0.45	0.68	0.23	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	0.00	36.43	0.00	0.24	0.24	0.49	0.24	0.73
mesothelioma cell line:Mero-48a	10852-111F6	4.43	30.34	1.55	0.66	0.44	0.89	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	69.64	33.11	0.79	0.79	1.05	1.31	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	0.17	44.77	0.34	1.36	0.68	0.85	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	142.06	13.14	0.25	0.00	0.25	0.51	1.01	0.51
mesothelioma cell line:Mero-95	10856-111G1	0.21	28.36	0.83	1.04	0.21	0.83	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	0.00	23.69	0.17	0.00	0.17	0.17	0.17	0.50
mesothelioma cell line:NCI-H226	10846-111E9	15.75	15.93	0.36	0.54	0.00	0.54	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	0.00	19.47	0.51	0.00	0.34	0.34	0.00	0.17
mesothelioma cell line:NCI-H28	10845-111E8	0.51	14.25	0.51	0.25	0.00	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	0.00	29.03	0.33	0.65	0.65	0.65	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	0.00	22.22	0.27	0.27	0.27	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	3.65	21.50	0.38	0.19	0.58	0.00	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	5.50	24.18	0.49	0.00	0.24	0.24	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	7.54	39.13	0.36	0.18	0.72	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	1.63	60.73	1.31	1.31	0.00	1.63	0.98	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	43.23	54.68	4.66	2.54	0.21	1.70	1.27	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	0.69	67.73	1.38	1.84	0.46	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1.14	20.93	0.19	0.19	0.38	0.19	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.00	52.85	0.37	0.55	2.22	0.37	0.37	0.37
myeloma cell line:PCM6	10474-106I6	13.44	43.68	0.40	0.59	1.19	0.20	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	30.94	65.95	1.52	0.51	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	7.26	28.83	0.20	0.39	0.59	0.20	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.38	66.52	2.01	1.89	0.45	0.11	0.11	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.34	52.66	1.69	1.91	0.66	0.37	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	34.22	56.30	1.66	2.21	0.55	0.00	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	54.75	100.54	3.22	1.61	2.07	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	48.27	83.63	0.94	0.00	1.87	0.19	0.00	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	192.33	83.93	4.64	3.59	0.42	0.84	1.69	1.27
neuroblastoma cell line:NH-12	10555-107I6	45.66	71.56	1.30	1.30	2.61	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	179.82	55.99	0.71	0.95	0.71	2.61	1.19	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	234.09	79.82	1.74	0.95	1.43	3.80	3.96	2.69
neuroectodermal tumor cell line:TASK1	10774-110F9	78.29	37.84	1.61	0.40	0.40	0.81	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	137.33	47.68	1.91	0.64	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	30.61	39.13	0.53	0.27	0.80	0.80	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.17	26.55	0.51	0.00	0.17	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	734.87	104.87	5.60	5.60	0.80	0.80	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	318.04	124.07	0.64	0.00	1.60	5.13	2.24	3.53
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	163.70	65.69	0.26	0.53	1.58	2.89	4.20	2.36
nucleus accumbens, adult, pool1	10037-101F1	401.86	220.94	8.62	7.31	3.56	0.47	0.56	1.22
occipital cortex - adult, donor10196	10172-103C1	98.90	152.47	6.18	4.12	0.00	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	85.34	126.94	1.61	0.81	1.88	0.00	1.07	0.81
occipital cortex, newborn, donor10223	10355-105E4	329.01	80.43	2.91	3.64	1.46	2.55	1.82	3.64
occipital lobe, adult, donor1	10076-102A4	266.86	197.85	3.67	3.41	2.62	2.62	3.94	1.57
occipital lobe, fetal, donor1	10073-102A1	105.13	102.98	3.00	2.15	2.15	2.15	1.72	0.86
occipital pole, adult, pool1	10036-101E9	342.57	270.35	7.25	6.86	3.47	0.79	0.63	0.79
olfactory region, adult	10195-103E6	197.17	152.27	4.20	2.87	2.10	1.91	1.15	1.72
optic nerve, donor1	10277-104E7	32.02	98.05	6.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	0.23	38.61	1.25	1.71	0.34	0.11	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.77	40.39	2.47	1.37	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	0.00	43.85	0.85	0.51	0.51	1.02	0.85	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	0.12	15.36	0.00	0.00	0.46	0.00	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	1.18	59.97	0.00	0.59	0.59	0.59	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	0.00	37.37	0.93	0.93	3.74	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	0.00	66.37	1.48	1.27	1.48	0.64	0.00	0.21
ovary, adult, pool1	10020-101D2	88.92	72.15	0.61	1.31	2.36	0.70	0.52	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	0.92	83.04	1.28	1.83	0.37	0.37	0.37	0.73
pancreas, adult, donor1	10049-101G4	22.58	121.34	0.94	5.64	1.88	0.94	1.88	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	58.98	38.02	0.56	0.00	0.28	0.56	0.56	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	0.17	51.28	0.34	0.68	0.34	1.70	1.19	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	0.00	58.28	0.83	0.33	0.00	0.00	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	347.78	246.19	6.96	4.85	3.75	0.46	1.01	1.37
parietal cortex, adult, donor10258	10373-105G4	172.49	111.57	2.94	8.07	1.47	1.47	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	112.86	119.44	3.76	4.70	0.00	2.82	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	119.72	137.10	4.56	1.43	2.85	1.43	1.71	0.57
parietal lobe, adult, pool1	10034-101E7	333.44	233.69	7.75	7.49	3.61	0.62	0.44	0.70
parietal lobe, fetal, donor1	10072-101I9	95.04	84.38	2.91	4.85	1.94	3.88	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	281.89	61.69	1.87	2.99	2.24	1.50	4.11	1.87
parotid gland, adult	10199-103F1	14.80	92.50	0.62	0.62	3.08	1.23	0.62	0.00
penis, adult	10200-103F2	25.24	63.38	1.61	0.54	1.07	1.61	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	60.99	29.38	1.30	0.74	0.93	1.12	0.37	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	0.00	37.73	3.21	2.19	0.29	0.58	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	181.25	410.88	16.77	15.48	9.03	0.65	2.58	4.52
pineal gland, adult, donor10252	10160-103A7	26.06	281.30	5.33	4.15	3.55	0.59	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	70.23	226.37	5.64	4.39	8.15	0.00	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	1017.87	264.08	4.05	9.11	3.04	20.24	10.12	7.08
pituitary gland, adult, donor10252	10162-103A9	454.99	273.10	2.61	5.21	4.17	1.04	3.13	0.52
pituitary gland, adult, donor10258	10378-105G9	337.94	181.31	0.85	3.40	4.26	6.81	0.85	1.70
placenta, adult, pool1	10021-101D3	103.20	103.42	0.75	0.75	2.37	0.54	0.43	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	7.15	29.93	0.26	1.06	0.93	0.13	0.13	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	0.62	75.64	1.40	1.09	1.56	0.16	0.31	0.62
pons, adult, pool1	10033-101E6	231.35	188.23	10.41	8.43	5.77	0.69	0.17	0.43
postcentral gyrus, adult, pool1	10032-101E5	365.09	278.61	8.89	5.23	4.36	1.39	1.57	1.13
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	23.01	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	23.47	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	24.33	39.62	1.02	0.87	0.29	0.87	0.15	0.44
prostate cancer cell line:PC-3	10439-106E7	15.97	22.87	1.09	0.73	0.00	0.36	0.18	0.18
prostate, adult, pool1	10022-101D4	70.01	78.99	0.82	0.82	1.81	0.36	0.63	0.36
putamen, adult, donor10196	10176-103C5	405.79	194.75	10.62	9.44	1.42	1.89	1.18	2.83
putamen, adult, donor10252	10152-102I8	127.45	84.31	5.88	3.92	0.00	3.92	5.88	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	183.59	62.29	0.00	1.09	0.00	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	293.32	131.92	3.62	2.66	1.21	0.97	1.69	0.97
putamen, newborn, donor10223	10365-105F5	131.19	35.23	1.50	0.75	2.25	2.25	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	16.29	25.31	1.75	1.16	0.00	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	116.84	77.90	2.78	1.39	0.00	0.00	1.39	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	0.21	47.91	2.33	2.12	0.42	0.21	0.64	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	0.41	74.97	1.66	1.66	0.83	0.41	1.66	0.00
retina, adult, pool1	10030-101E3	109.64	145.82	1.49	2.58	2.68	0.89	0.60	0.10
retinoblastoma cell line:Y79	10475-106I7	10.91	38.19	1.30	0.52	0.52	1.04	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	17.58	31.47	0.98	1.11	0.12	0.37	0.37	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	0.56	93.08	2.53	2.25	0.28	0.00	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	212.20	83.36	0.76	0.00	0.00	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	73.64	66.04	1.62	2.43	1.13	0.49	0.49	0.97
salivary acinar cells, donor2	11772-123I8	165.09	65.13	0.96	2.62	0.83	1.79	2.89	2.07
salivary acinar cells, donor3	11773-123I9	129.10	74.81	2.65	1.99	1.32	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	20.02	125.83	0.57	3.43	1.72	0.00	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	0.00	18.38	0.08	0.00	0.00	0.08	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	0.12	25.98	0.12	0.24	0.35	0.24	0.00	0.00
seminal vesicle, adult	10201-103F3	27.51	74.60	0.53	0.00	1.59	1.59	2.12	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	0.24	21.62	0.73	0.00	1.94	0.00	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	4.53	60.89	0.50	0.50	1.01	0.25	1.01	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	8.03	20.07	0.00	0.00	1.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	537.55	85.02	0.81	2.01	0.40	2.69	2.42	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	15.81	0.44	0.22	0.11	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	2.58	13.81	0.00	0.13	0.13	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	3.55	70.22	1.42	0.71	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	13.19	60.21	0.36	0.84	0.84	0.12	0.36	0.12
skeletal muscle, fetal, donor1	10066-101I3	107.54	89.45	3.02	3.02	3.02	3.02	5.03	2.01
skin, adult, donor1	10074-102A2	47.50	33.93	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	97.84	106.68	0.63	0.00	0.00	1.89	3.79	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	1.33	170.10	6.34	6.34	2.00	1.67	1.67	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	64.62	84.48	10.72	11.03	1.26	2.52	4.10	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	146.49	106.01	2.70	0.77	2.31	1.73	3.66	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	0.00	41.37	3.63	1.48	1.15	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	16.89	85.89	1.13	1.77	0.00	0.80	0.80	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	43.58	91.09	5.67	4.79	0.65	0.44	0.22	0.22
small intestine, adult, pool1	10024-101D6	44.19	62.23	0.60	0.24	2.15	0.36	0.12	0.12
small intestine, fetal, donor1	10064-101I1	105.16	45.21	1.23	0.49	1.47	1.47	1.47	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.39	117.45	1.03	1.54	1.54	7.18	7.69	4.10
smooth muscle, adult, pool1	10048-101G3	21.97	55.05	0.52	0.78	0.78	0.26	1.03	0.78
somatostatinoma cell line:QGP-1	10781-110G7	0.80	187.35	10.18	10.72	2.41	0.00	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	55.29	85.80	1.61	1.15	1.38	1.38	1.38	2.52
spinal cord, adult, donor10252	10159-103A6	33.91	76.49	1.18	0.39	0.79	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	29.75	93.39	1.38	0.69	2.77	2.08	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	175.02	139.04	1.22	4.27	4.27	4.27	2.44	2.44
spinal cord, newborn, donor10223	10359-105E8	70.26	46.84	0.92	0.00	3.21	1.84	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.85	62.88	0.60	0.45	0.75	0.15	0.00	0.15
spleen, adult, pool1	10025-101D7	230.40	41.52	0.33	0.77	1.87	0.55	0.44	0.66
spleen, fetal, pool1	10044-101F8	137.30	52.52	0.40	0.24	1.35	0.40	0.79	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	19.25	11.18	0.21	0.10	0.10	0.10	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.78	32.47	1.14	1.33	1.14	0.19	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	174.73	96.45	4.19	4.19	2.45	4.19	3.49	3.15
squamous cell carcinoma cell line:T3M-5	10616-108G4	31.27	48.08	2.74	1.17	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1.91	104.79	1.46	1.91	1.69	0.45	0.45	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	233.83	29.23	0.42	0.00	0.00	4.66	3.81	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.04	11.85	0.00	0.00	0.42	0.42	0.00	0.42
stomach, fetal, donor1	10062-101H8	43.79	77.96	0.00	2.14	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	14.24	66.65	0.57	1.14	4.56	0.00	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	271.37	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	22.02	100.32	0.42	0.00	0.83	0.00	1.04	0.83
substantia nigra, adult, donor10258	10371-105G2	130.35	142.24	2.59	3.10	1.55	0.52	2.07	1.03
substantia nigra, newborn, donor10223	10358-105E7	33.21	29.68	0.71	0.71	2.12	0.71	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	0.69	71.30	0.92	1.38	0.69	0.23	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	534.82	275.25	7.04	6.61	4.83	2.37	1.53	1.95
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	166.67	123.93	4.27	5.70	4.99	7.12	4.99	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	184.17	99.34	5.27	3.52	1.76	1.76	3.52	3.52
tenocyte, donor1	11763-123H8	89.37	129.87	1.75	2.09	1.75	4.19	2.79	2.09
tenocyte, donor2	11765-123I1	93.85	140.39	0.76	0.76	1.14	2.29	0.76	1.91
tenocyte, donor3	11768-123I4	56.34	105.64	0.74	0.37	0.74	1.85	2.59	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	90.59	33.82	0.85	0.34	1.02	0.51	1.02	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	99.73	21.89	0.46	0.31	0.62	1.23	1.54	1.23
teratocarcinoma cell line:PA-1	10807-111A6	85.24	38.28	0.31	0.62	0.15	0.46	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	45.70	26.53	0.89	0.51	1.27	0.38	0.38	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	138.03	60.89	0.76	0.38	0.38	1.13	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	29.12	30.43	0.11	0.76	0.33	0.11	0.44	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	44.62	12.05	0.00	0.33	1.30	1.30	0.00	0.33
testis, adult, pool1	10026-101D8	68.07	88.26	1.29	0.64	1.83	0.75	0.64	0.64
testis, adult, pool2	10096-102C6	51.42	105.55	0.00	0.45	3.16	2.26	4.51	0.45
thalamus - adult, donor10196	10168-103B6	50.78	119.23	5.52	2.21	2.21	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	48.92	114.24	1.09	0.94	2.19	0.94	0.63	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	130.87	107.77	0.00	1.54	6.16	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	85.14	78.39	3.13	1.81	1.32	3.13	1.32	1.98
thalamus, newborn, donor10223	10366-105F6	104.13	59.26	2.30	4.03	1.15	2.88	0.58	2.30
throat, adult	10209-103G2	32.21	64.17	0.25	1.75	1.25	0.25	0.50	0.25
throat, fetal, donor1	10061-101H7	92.02	70.69	2.44	1.52	0.61	0.61	0.91	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	38.16	18.88	0.60	0.60	0.40	0.79	0.00	0.20
thymus, adult, pool1	10027-101D9	44.54	36.88	0.50	0.60	1.59	0.10	0.30	0.10
thymus, fetal, pool1	10043-101F7	68.68	53.10	1.45	0.31	1.77	0.31	0.21	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	1.06	31.38	0.13	0.13	0.27	0.13	0.00	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	52.38	46.10	0.42	1.40	1.40	0.28	0.28	0.56
thyroid, adult, pool1	10028-101E1	29.21	81.65	0.75	1.31	1.77	0.84	0.56	0.09
thyroid, fetal, donor1	10060-101H6	45.09	73.03	0.79	3.16	1.05	0.53	1.05	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	61.59	0.00	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	20.23	41.17	0.70	0.47	0.47	0.23	0.70	0.93
tongue, fetal, donor1	10059-101H5	46.50	73.30	1.18	0.39	0.00	1.97	1.18	0.79
tonsil, adult, pool1	10047-101G2	43.68	56.30	0.60	0.40	0.80	0.00	0.10	0.20
trachea, adult, pool1	10029-101E2	47.36	47.44	0.57	1.55	1.80	0.33	0.41	0.33
trachea, fetal, donor1	10058-101H4	61.55	76.55	2.69	1.54	2.31	0.77	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	55.27	31.88	0.35	0.35	0.35	0.35	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	0.10	32.32	0.71	0.91	0.91	0.00	0.10	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	0.16	37.76	0.78	1.10	0.31	0.00	0.31	0.00
tridermal teratoma cell line:HGRT	10694-109G1	226.40	58.98	0.00	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	0.00	35.64	0.68	0.68	0.34	0.17	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	123.10	58.42	0.00	2.09	4.17	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	40.44	92.14	0.68	1.02	1.02	0.51	0.51	0.17
uterus, fetal, donor1	10055-101H1	124.40	92.66	0.51	1.02	0.00	1.02	0.00	0.51
vagina, adult	10204-103F6	12.92	57.51	0.65	1.29	0.65	0.00	0.65	0.00
vein, adult	10191-103E2	68.17	59.18	0.66	0.66	1.32	0.66	2.19	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.40	26.44	1.07	0.27	0.00	0.00	0.00	0.27